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ABSTRACT
Biologic drugs, or large molecule drugs, such as monoclonal antibodies, are
proteins that are manufactured in living cells. Many biologics, such as Humira and
Enbrel, provide thousands of patients worldwide with lifesaving therapies. In order to
produce these drugs, different expression systems, like Chinese hamster ovary (CHO)
cells, are used. CHO cells are the most widely utilized mammalian cell line for
recombinant protein production due to a long history of regulatory approval for
producing safe biologic drugs and have the ability to produce therapeutic proteins at an
industrial scale. CHO cells have many advantageous characteristics, like producing
proteins with desired post-translational modifications. Many methods over the last 30
years have been used to improve productivity, including strain selection, media
improvements, and physiologic studies. Yet despite significant improvements in yields
and productivity, a major current drawback to using CHO cells is high production costs
due to low product yields.
The recent increased availability of CHO genome information has provided
fundamental knowledge needed to conduct studies to better understand CHO cell
physiology. Transcriptomic studies allow for quantitative measures of gene expression
changes when cells are grown in different culture conditions. In this study, the effects of
culture temperature and pH for two CHO cell lines, a non-recombinant CHO K1-PF cell
line and a recombinant rCHO DP-12 cell line was quantified using RNA-Seq to
characterize the transcriptome. The culture temperatures compared were 37°C and 33°C,
where 37°C represented the standard culture temperature. The 33°C culture temperature
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represented a reduced culture temperature used to increase cell viability and sustain
productivity in industry. The media pH levels examined were pH 6.95, a control level,
and pH 6.70, a low pH level. At lower pH levels, lactate consumption is often observed to
occur more readily.
The impact of pH on the transcriptome for both cell lines was determined to not
be significant. The impact of temperature on the transcriptome, however, was determined
to be significant and similar between the two cell lines. A total of 4184 genes were
identified as temperature sensitive for the union of differential expressed genes for each
cell line (FDR ≤ 0.05). Several genes related to glycosylation, apoptosis, and cell cycle
were identified as temperature sensitive. The gene ontology analysis identified additional
biological processes that could explain improved glycosylation at reduced temperatures.
Specifically, glycosylation genes, like Man1a1 and Man2a1, had higher expression for
both CHO K1-PF and rCHO DP-12, and are linked to improving protein glycosylation at
lower temperatures.
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CHAPTER 1
INTRODUCTION
1.1 SIGNIFICANCE
Biologics, like the anti-inflammatory drug Humira (Adalimumab) and the cancer
drug Herceptin (Trastuzumab), are drug substances made from living organisms used in
the prevention or treatment of diseases. Some of these living organisms include
Escherichia coli, yeast, and mammalian cell lines, such as Chinese hamster ovary (CHO)
cells. CHO cells are used to produce over 70% of all recombinant therapeutics today by
market value. In 1987, the FDA approved tissue plasminogen activator, the first CHOderived recombinant protein, for use as a biotherapeutic drug. Since then, 374 individual
biopharmaceutical products have gained a license in the United States and the European
Union (Walsh 2018). The use of CHO cells as a host cell line has exploded in the last few
decades due to capacity of these cells for human-like post-translational modifications.
This has led researchers to focus on powerful gene amplification systems that help to
produce higher concentrations of the desired products. Also, the demand for CHOderived biotherapeutics has led to more than 100-fold yield improvements in the last few
decades. Some of these yield improvements can be attributed to using serum-free media
and optimizing feeding strategies (Kim, et al. 2012; Dean and Reddy 2013).
In this study, two CHO cell lines were used. The first was CHO K1-PF, an
adapted version of the ancestral CHO K1 cell line. The other was a recombinant CHO
cell line, rCHO DP-12. The two parameters studied in this work were culture temperature
and pH. The culture temperatures were 37°C (control) and 33°C (mild hypothermic
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condition). The two initial culture pH values were pH 6.95 (control) and pH 6.7 (low).
Hypothermic cultures are used with CHO cells to improve cell viability and reduce
product degradation, and reduced culture pH conditions are used to promote lactate
consumption. In order to assess the underlying causes observed when the culture changes
are made, a transcriptomics approach was utilized, where RNA samples were extracted
during the growth phases of paired cultures. The overall goal of this study is to advance
the understanding of how CHO cells react to these different conditions, and to determine
if CHO cell line engineering might be feasible to implement the positive effects of
reduced temperature and pH without changing the culture conditions.
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1.2 PRIOR WORK
The RNA-Seq data used in this paper was collected by Yogender K. Gowtham as
part of his dissertation research (Gowtham 2016). This Master’s thesis is an extension of
his dissertation work. The outcome of this analysis of the RNA-Seq data collected by Dr.
Gowtham will lead to a co-authored manuscript that will include authors Dr. Christopher
A. Saski and Dr. Sarah W. Harcum.
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1.3 ORGANIZATION OF DOCUMENT
This Master’s thesis is divided into four chapters. Chapter One presents the
explanation of parameters used and organization of the document. Chapter Two contains
a brief literature review of biologics production, the use of Chinese hamster ovary cell
lines, RNA sequencing, transcriptome analyses, and the bioprocessing parameters
temperature and pH. Chapter Three presents the results of the transcriptome analyses,
where the effects of reduced culture temperatures and low culture pH on two CHO cell
line transcriptomes are explored. Finally, Chapter Four summarizes the work presented as
well as discusses future directions. The Appendix contains three sections. Appendix A
contains the sample descriptions. Appendix B contains a multidimensional scaling
(MDS) plot for all samples. Appendix C lists the genes that were identified as
temperature sensitive in at least one of the cell lines.
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CHAPTER 2
LITERATURE REVIEW
2.1 Biologics Production
Recombinant DNA technologies have revolutionized the way researchers
approach medicine. At the center of the early breakthroughs of recombinant DNA was
Stanford University, where researchers slowly began to discover how genes from one
organism can be isolated, cloned into vectors, and expressed in other, unrelated
organisms. In 1976, Herbert Boyer founded Genentech, and after partnering with Eli
Lilly, helped produce the first FDA approved recombinant DNA product, Humulin, in
1982 (Kinch 2015). Since Humulin hit the market, the biologics market has increased
exponentially, where global sales for biologics exceeded $200 billion in 2016. Due to this
rapid growth, pharmaceutical companies are faced with many economic pressures
(Radhakrishnan et al. 2018). In order to tackle this problem head on, research and
development into improving productivity of biologic drug production is vital in keeping
up with the ever-increasing demand for these drugs.

2.2 Chinese Hamster Ovary cells
Chinese hamster ovary (CHO) cells are used for recombinant production because
of this cell line’s ability to be grown in suspension in serum-free and chemically-defined
culture medium, as well as in large-scale industrial-sized bioreactors with high
production rates (Lolonde and Durocher 2017). Additionally, CHO cells have the
capability to synthesize proteins that are comparable to those found in humans with
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respect to biochemical properties and molecular structures. The productivity of
mammalian cells cultivated in bioreactors has reached 10-15 g/L of monoclonal
antibodies as a result of media optimization, selection methods, and process control (Zhu
et al. 2012). Yet, these production levels are still low such that CHO cell protein
production costs, like the monoclonal antibody drug Herceptin, are over $100,000 for a
year’s worth of treatment (Kurian et al. 2007). Thus, there is still a need to further
improve these processes.
A well-established manufacturing process for recombinant proteins in mammalian
cells, like CHO, follows a conventional scheme. First, the recombinant gene with the
necessary transcriptional regulatory elements is transferred to the cells, along with a
second gene that confers to recipient cells a selective advantage. In the presence of the
selection agent, only those cells that express the selector gene survive. Some common
genes used for selection in CHO cells are dihydrofolate reductase (DHFR), an enzyme
involved in nucleotide metabolism, and glutamine synthetase (GS). Other areas of host
cell engineering include approaches to reduce lactate accumulation, manipulate cell
growth, and decrease programmed cell death (Li 2010). Following selection, survivors
are transferred as single cells to a second cultivation vessel, and the cultures are expanded
to produce clonal populations. To generate stable cell lines with adequate productivity,
hundreds to thousands of clones may be screened, where individual clones are evaluated
for recombinant protein expression. The highest protein producers are then selected,
where further work focuses to improve productivity by varying media formulations and
process parameters (Wurm et al. 2004; Li et al. 2010).
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One important attribute of CHO cells is the capability of producing recombinant
glycoproteins with human-like glycans. In this manner, the biologic drugs are more likely
to be bioactive in human hosts and not cause immune reactions. The glycosylation profile
of a biologic drug is considered a critical quality attribute as it effects how well it will
function in a patient. (Zhang et al. 2016). Protein glycosylation is the addition of
oligosaccharides onto a protein, mediated by many complex metabolic reactions and
subdivided into N-linked and O-linked glycosylation. N-linked glycosylation is
characterized by the attachment to an asparagine-residue in the protein, while O-linked
glycosylation is the attachment to the oxygen atom of serine or threonine (Goh and NG
2017). In industrial processes, the large repertoire of glycans is not observed on
recombinant glycoproteins expressed by CHO cells unlike if these same proteins were
produced in plant cells or yeast. Additionally, control of these metabolic pathways has
been tailored by cell line selection, cell culture media optimization, and altering
bioprocess parameters (Hosslet et al. 2009). Therefore, controlling the glycan
composition and structure of biologics for molecules such as immunoglobulin G proteins
(IgGs) appears to be a promising method to improve the efficacy of therapeutic
antibodies that utilize antibody-dependent cellular cytotoxicity (ADCC) for biological
activity (Li et al. 2010).
In 2011, the genomic sequence of the parental CHO-K1 cell line was determined,
marking a major milestone for the cellular and metabolic engineering of CHO cell lines.
This genome sequence predicted that CHO-K1 cells had more than 24,000 genes (Xu et
al., 2011). More recently, the CHO-K1 cell line genome is estimated to have 24,383
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genes (Lewis et al. 2013, Xu et al. 2011). These improvements to the CHO genome have
led to more site-specific cell line engineering to increase viable cell densities (VCDs) and
specific productivity (qp) (Kim et al. 2012; Ritter et al. 2016; Tossolini et al. 2018;
Tamošaitis and Smales 2018).

2.3 RNA Sequencing
The transcriptome is the complete set of transcripts in a cell for a specific
physiological condition, where the number of each transcript is also quantified.
Quantifying the transcriptome is essential for interpreting the functional elements of the
genome (Wang et al. 2009). Formerly, the most powerful tools for transcriptome studies
were DNA mircroarrays, RNA interference, and quantitative real-time PCR (q-RT-PCR)
(Datta et al. 2013). Another commonly used method, northern blots, were limited to
measuring single transcripts, whereas DNA microarrays could analyze hundreds of genes
at once (Kukurba & Montgomery 2016). The recent reductions in sequencing costs
coupled to not needing a sequenced organism and the ability to attain more information
from a single analysis has led researchers to switch from DNA microarray analysis to
RNA sequencing (RNA-Seq) (Chen et al. 2015; Melville et al. 2011; Doolan et al. 2013;
Reinhart et al. 2018).
RNA-Seq is a high-throughput next-generation sequencing (NGS) technology that
essentially reads every mRNA transcript in a cell in a template independent manner. The
mRNA in a cell is first transcribed into complementary DNA (cDNA) prior to reading,
which improves sample stability. Every read of the cDNA is counted, and these counts
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of the cDNA sequence are integer numbers. The cDNA reads are also mapped onto the
genome to develop a full representation of the number of transcripts for each gene that
were in the cell. (Rahmatallah et al. 2014, Kukurba & Montgomery 2016).
The typical RNA-Seq experiment involves several steps. First the RNA is isolated
and converted to cDNA. The cDNA is prepared (fractionated) and sequenced using a
next-generation sequencing platform (Kukurba & Montgomery 2016). Ensembleplatforms use fractionated cDNA resulting in short sequences from both ends (paired-end
sequencing) and then are reassembled to form genes (Wang et al 2009). There are several
important factors that affect the quality of the transcript data. For example, the greater
number of transcripts that can be detected and quantified, the higher the quality of the
data. The terms used to assess the quality of this data are error rates, sequencing depth, or
number of reads per sample, and library size (Mortazavi et al. 2008 and Conesa et al.
2016). The Illumina sequencing platform used in this study uses an ensemble-based
platform, which has been shown to give low sequencing error rates (Bentley et al. 2008).

2.4 Transcriptome Analyses
Once the sequencing is completed for an RNA-Seq sample, FASTQ files are
generated for subsequent analyses. Pre-processing of short read sequences can be
accomplished with packages such as CutAdapt (Martin 2001), ngsShoRT (Chen et al.
2014), and Trimmomatic (Bolger et al. 2014). The purpose of these packages is to
identify and remove adapter sequences and perform quality filtering. Succeeding this step
is alignment to a reference genome, where STAR and TopHat2 are the most commonly
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used packages. STAR (Spliced Transcripts Alignment to a Reference) uses a novel
strategy for spliced alignments, where it is advantageous for its high mapping speed and
accuracy when dealing with large transcriptome datasets. TopHat2 is optimized for
widely available long paired-end reads, which can cause an issue by spanning multiple
splice sites rather than just one or two. For counting reads mapped to a reference
genome, htseq-count function in HTSeq, the summarizeOverlap function in the
GenomicRanges Bioconductor package, and the tool featureCounts are the most
frequently cited tools. featureCounts is used mainly for its processing speed and memory
efficiency (Liao et al. 2014). HTSeq is one of the simplest quantification methods used to
count how many aligned reads for each gene overlap its exons. When compared with
other aligners, HTSeq frequently shows up at the top of the performance rankings
(Anders et al 2014; Fonseca et al. 2014).
There are several public domain tools to assist with analyzing transcriptome data.
These differential gene expression tools include edgeR, limma, and DESeq2. All of these
software tools conduct statistical tests of raw RNA-Seq data and organize it. There are
several review articles that have directly compared the analysis tools in real and
hypothesized data to determine false positives and false negatives (Costa-Silva et al.
2017). One package, edgeR, moderates the dispersion estimate for each gene toward a
common estimate across all genes, using a weighted conditional likelihood (Robinson et
al. 2009). Limma, another common package, uses linear models to analyze entire
experiments as an integrated whole rather than making comparisons between pairs of
treatments. The limma software conducts this by assessing which genes are significantly
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different, as well as collecting information about the expression level of each gene in a
pairwise fashion (Ritchie 2015; McDermaid et al. 2018). DESeq2 analysis begins with
constructing a count matrix K with rows indicating genes and columns indicating
different samples used. For each gene, a generalized linear model (GLM) is fit, where
read counts follow a negative binomial distribution. When comparing test and control
samples, the GLM fit returns coefficients that indicate overall expression strength of
genes and the log2 fold changes. DESeq2 is primarily used to control for false positives.
For both real data and hypothetical data sets, DESeq2 often achieved the highest
sensitivity while also able to maintain accurate false discovery rates (FDR) (Love et al.
2014; Seyednasrollah et al. 2015).
Once differentially expressed genes have been identified, tools to find patterns in
the transcriptome include GSEA algorithm (gene set enrichment analysis), GSA (gene-set
analysis), and SAFE (spatial analysis of functional enrichment). While these different
methods vary in statistics, all of these methods use the framework of statistical hypothesis
testing by assigning p-values to a gene set (Maciejewski 2013). Key elements of GSA are
the presence of known gene sets that are tested against, the type of hypothesis being
tested and a method of controlling false positives. Known gene sets, or knowledge-based
resources, include gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes
(KEGG), and Molecular Signatures Database (MSigDB) (Mathur et al. 2018). Usually,
multiple sets of tools will be used during the transcriptome analysis processes, as
different insight can be gained from each tool.
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KEGG is a knowledge base for analysis of gene functions that links genomic
information with higher order functional information. Because KEGG Orthology system
represents conserved features of genes and maps, it is a widely used resource for
transcriptome analysis (Kanehisa & Goto 2000; Kanehisa et al. 2019). Limitations of the
KEGG orthology system include not assigning “LOC” genes to a specific pathway. LOC
genes are those that are not yet functionally characterized. Another knowledge-based
resource, GO, is an evidence-based annotation tool used to explain the biological roles of
individual genomic products, like genes, by classifying the genes with ontologies. The
three major ontologies used are molecular function, biological process, and cellular
components. A ‘GO annotation’ describes an association between an ontology, like
biological processes, and a gene product. One advantage of GO is that for each
annotation, it provides references to the evidence that support that association (Ashburner
et al. 2000; The Gene Ontology Consortium 2015). While the GO database is beneficial
in classifying genes based on a specific orthology, the reliability of the statistical
significance tests of GO terms have been questioned (Mao et al. 2005). To discover
significantly enriched GO terms, PANTHER database (Protein Analysis THRough
Evolutionary Relationships) can be used, which classifies genes from 104 organisms by
structured representation of protein function. This includes the GO annotations and
biological pathways. The PANTHER database is often used for gene set analysis because
it not only assigns GO terms, but also provides associations of genes to biological
pathways from the PANTHER Pathway resource (Mi et al. 2017).
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2.5 Temperature and pH Analyses
Most mammalian cells, like CHO, are cultivated at 37°C to mimic near the natural
organism temperature (Yoon, et al. 2003). While standard conditions are still commonly
used, research has shown that reduced culture temperatures can produce a range of
positive results. Typically, reducing culture temperatures from 37°C to temperature
ranges between 28°C to 34°C for CHO have been shown to increase cell viability and
productivity. Also, at reduced culture temperatures, decreased nutrient uptake has been
observed, with optimal outcomes being dependent upon the cell line used and the desired
product (Bedoya-López et al. 2016; Fox, et al. 2005; Kumar, et al. 2007; Sunley, et al.
2008; Bedoya-López, et al. 2016; Swiderek et al. 2007; Vergara et al. 2014). Moreover,
when cells are cultivated at sub-physiological temperatures, global protein synthesis rates
are decreased. While this seems counterintuitive, the recombinant protein expression has
been observed to increase at these reduced temperatures due to less competition of
recombinant mRNAs with endogenous mRNAs for the translational and protein folding
machinery (Masterton and Smales 2014). While reducing culture temperature increases
product yields, it can also have a significant impact on product quality, where
glycosylation and protease degradation are often reported to be affected by temperature
(Yoon et al. 2003b; Woo et al. 2008; Sou et al. 2015).
Glycosylation is a critical product attribute of recombinant proteins because of its
influence on stability, folding and intracellular trafficking. The degree of protein
glycosylation is dependent upon amino acid composition, rate of synthesis, posttranslational modification capability of hosts, and culture conditions (Gupta and Shukla
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2018). The stabilization of physical properties of therapeutic proteins are imperative for
the in-vivo efficacy of biologic drugs, which may be hindered by physicochemical
instabilities of inappropriate glycosylation (Yamane-Phnuki & Satoh 2009). For example,
the charge and solubility of recombinant proteins are influenced by the presence of
charged monosaccharides like sialic acids. The negative charge of sialic acids has been
shown to enhance the in-vivo stability of recombinant proteins (Runkel et al. 1998; Raju
2008; Costa 2014). Additionally, sialidases and proteases secreted by living cells or
released into the culture upon cell death can play a significant role in the heterogeneity of
the product. Therefore, decreasing culture temperatures is thought to protect product
quality by decreasing protease and sialidase activity (Dorai and Ganguly 2014; Chuppa et
al. 1996).
Cell cycle is another critical process characteristic that affects recombinant
protein production. Specifically, genes involved in protein translation and ribosome
biogenesis have higher expression in the G1 phase (Kumar et al. 2007; Moore et al. 1997;
Yoon et al. 2003; Kaufman et al. 1999; Fogolin et al. 2004). Reduction of culture
temperature has also been shown to cause G1-phase cell cycle arrest and resulted in
improved protein productivity through a prolonged stationary phase (Tossolini 2018;
Masteron and Smales 2014). Another process characteristic affecting protein production
is apoptosis, a form of programmed and controlled cell death. Apoptosis lowers cell
viability in CHO cell cultures and reduces overall productivity of upstream process
development (Carlage et al. 2009). Understanding the factors that cause apoptosis as well
as developing strategies to protect cells against it could lead to improved bioprocess
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development (Grillo & Mantalaris 2019; Wong et al 2005). A decrease in culture
temperatures showed the onset of apoptosis being delayed significantly, which was
hypothesized to be a result of a reduction of cellular metabolism (Al-Fageeh & Smales
2006; Moore et al. 1997; Grilo and Mantalaris 2019). Additionally, several studies have
observed that for CHO cells, reduced culture temperatures resulted in elevated cold shock
protein expression, such as RNA binding motif protein 3 (Rbm3) and cold inducible
RNA binding protein (Cirbp) (Sonna et al. 2013; Jones and Inouye 1994; Al-Fageeh &
Smales 2006). A few studies also showed decreased heat shock protein expression in
reduced culture conditions, and gene expression changes for CSPs and HSPs following a
temperature reduction have been noted (Bettaieb & Averill-Bates 2005; Sonna et al.
2013; Lee et al. 2009).
Studies have shown that changes in pH can have a significant impact on cell
growth rate, cell density, lactate production rate, and protein productivity and quality
(Radhakrishnan 2018; Zheng et al. 2018; Hossler 2009). Raising and lowering culture pH
has been examined, where primarily only lowering the culture pH promotes positive
outcomes in CHO productivity and in extending culture durations (Trummer et al. 2006;
Jiang et al 2018; Ivarsson et al 2014). Oguchi noted that combining reduced culture
temperatures with lowering culture pH increased cell viability and increased the final
antibody titer compared to control (Oguchi et al 2007). Other studies, however, have
shown that decreasing culture pH could give rise to detrimental effects on cell production
yields because it halts cell growth and can give rise to changes in cell metabolism (Varley
and Birch 1999; Sauer et al. 2000). Overall, there appears to be a low pH range that
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improves productivity by improving lactate utilization. However, culture pH levels that
are too low can cause cell growth inhibition. Therefore, the best range of pH for CHO
cells appears to be from 6.70 to 7.2.

16

CHAPTER 3
A TRANSCRIPTOMICS APPROACH TO INVESTIGATING LOW CULTURE
TEMPERATURE & LOW MEDIA PH CONDITIONS IN TWO CHO CELL
LINES
3.1 Introduction
The global biologics market was $221 billion in 2017, and there are currently over
1000 biologics under development. The widespread use of CHO cells in recombinant
protein production, in comparison to other mammalian cells, is a result of an established
record of product safety, product quality, and desirable process performance
characteristics (Wuest et al. 2012; Farrell et al. 2014; Wurm 2004; Dean and Reddy 2013;
Tejwani et al. 2018). As of 2018, CHO cells produced 84% of the monoclonal antibody
drugs of those produced in mammalian cells. CHO cells are also used for producing
complex proteins such as cytokines and fusion proteins (Walsh 2018; Zhu 2012; Matasci
et al. 2009).
To better understand CHO cellular mechanisms under certain physiological
condition, a transcriptomics approach can be utilized. RNA sequencing (RNA-Seq) has
become the primary method for transcriptome analysis due to lower costs, wider
coverage than DNA microarrays, and greater dynamic range (Conesa et al. 2016; Wang
et al. 2009; Fonseca et al. 2014; Mortazavi et al. 2008). For CHO cells, the availability of
a reference genome has improved mapping of sequences with identities (Xu et al. 2001;
Datta et al. 2013; Tossolini et al. 2018; Monger et al. 2015; Sha et al. 2018).
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For some time, both temperature and pH have been known to effect CHO cell
growth, protein productivity, and critical product quality attributes (Hossler et al. 2009;
Vergara et al. 2014; Fox et al. 2005). Often, the culture temperature will be reduced midculture to reduce cell metabolism, arrest cell growth, and increase productivity (Yoon et
al. 2003a, 2005; Bedoya-López 2016; Lolonde and Durocher 2017; Kaufmann et al.
1998; Kumar et al. 2007; Trummer et al. 2006). While higher cell viability has been
shown to be a universal result of reduced culture temperatures, the effects of reducing the
culture temperature on protein productivity has had variable results. In some studies it
was observed that glycoprotein quality and productivity decreased for CHO cells
(Vergara et al. 2018; Yoon et al. 2003a), while other studies observed substantial
increases in protein productivity (Bedoya-López et al. 2016; Al-Fageeh et al. 2006;
Kantardjieff et al. 2010; Kaufmann et al. 1998; Woo et al. 2008; Trummer et al. 2006).
Others, however, have demonstrated that the effect of reducing the culture temperature
are cell line and protein specific (Yoon et al. 2003b; Yoon et al. 2004). Culture pH has
also been observed to affect growth rates, protein productivity and product quality
(Radhakrishnan et al. 2018). One study showed that reducing the pH of a CHO cell
culture to pH 6.85 increased cell viability (Zheng et al. 2018). Other studies have shown
that lowering the culture pH can enhance specific productivity (Oguchi et al. 2006; Xie et
al. 2016; Trummer et al. 2006). Therefore, there is a need to better understand the
underlying transcriptional changes that occur in CHO cells at reduced culture
temperatures and pH levels.
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In this study, the impact of culture temperature and pH was examined using a
transcriptome analysis. RNA-Seq was used to obtain the full transcriptome of two
different cell lines cultured at two different temperatures and with two different initial pH
levels. The two temperatures used were 37°C and 33°C and two initial pH levels were pH
6.95 and pH 6.70. 37°C and pH 6.95 represented the standard conditions, and 33°C and
pH 6.70 represented the reduced temperature and low pH conditions, respectively. The
two cells lines used were CHO K1-PF, a non-recombinant host cell line, and rCHO DP12, a recombinant cell line expressing anti-IL-8. The transcriptomes were analyzed for
differential gene expression due to temperature and pH. Important bioprocess-related
gene expression levels were examined, as well as cold and heat shock genes. Gene
ontology methods were then used to identify gene expression patterns between the cell
lines.
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3.2 Materials and Methods
3.2.1 Cell Lines, Culture Conditions, and RNA Extraction
CHO K1-PF (Sigma 00102307), a non-recombinant CHO cell line derived from CHOK1, and a recombinant CHO cell line rCHO DP-12, clone #1932 (ATCC® CRL-12445TM),
which expresses a monoclonal antibody (mAb) against the chemokine Interleukin-8 were
used. Both cell lines were grown in CD CHO medium (Life technologies, NY, USA).
The cells were cultured in 75 cm2 T-flasks in incubators with 5% CO2 maintained at
either 33°C or 37°C. The CD CHO media had an initial pH of 6.95. To obtain pH 6.70,
1.2N HCl was added. The pH was measured with an UltraBasic benchtop pH meter UB10 (Denver Instruments). Cell viabilities and concentrations were measured using
TC20TM Automated Cell Counter (Bio-Rad). Duplicate cultures were conducted for each
condition examined. For the RNA-Seq analysis, samples were harvested once the cells
reached a concentration of greater than 2.0 x 105 cells / mL. Samples were added to
RNAprotect® cell reagent (Qiagen, Valecia, CA) immediately upon removal from Tflasks. Samples in RNAprotect® were stored at 4°C overnight or at -20°C for up to a
month before processing the RNA.

3.2.2 RNA-Sequencing
The messenger RNA (mRNA) was purified using oligo-dT attached magnetic
beads, and the cleaved RNA fragments were copied into first strand cDNA using reverse
transcriptase. The second strand cDNA synthesis was performed using DNA Polymerase
I, and the cDNA fragments went through an end repair process with the addition of an
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‘A’ base and ligation of the adapters. The cDNA libraries were quality validated on an
Agilent 2100 Bioanalyzer System to confirm correct fragment distribution (~260 bp) and
effective removal of adapter dimers. Sequence libraries were multiplexed, and sequence
data was collected on 2 lanes of a HiSeq 2500 (Illumina, San Diego, CA) at the
Genomics division of David H. Murdock Research Institute (Kannapolis, NC) using a
2×101 bp, paired end read type.

3.2.3 Quality Control and Trimming Raw Data
Once sequencing was completed, the raw data files were output as FASTQ files,
which contained the nucleotide sequences for each read along with base quality scores.
The FASTQC package (v0.10.1) conducted quality control checks including per base
sequence content, per sequence GC content, and adapter content. (Andrews et al. 2010,
Monger et al. 2015). Then, the Trimmomatic Package (v0.38) was used for quality
trimming, adapter removal, and read filtering (Bolger et al. 2014).

3.2.4 Mapping and Counting Reads
Following Trimmomatic, STAR(v2.7.0) was used to generate genome index files
using the genome Fasta file as the input, where the Chinese hamster genome reference
was used (RefSeq GCA_003668045.1). Next, reads were mapped to the genome using
STAR, which generated a BAM (Binary Alignment Map) output file (Dobin et al. 2015).
Samtools (v1.9) was used to convert the BAM files to SAM (Sequence Alignment Map)
files as an input for HTSeq (Li et al. 2009). Finally, HTSeq (v0.11.0) was used to count
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the number of reads mapped to each gene, called a feature in HTSeq. The output from
HTSeq was used for differential expression analysis using the package DESeq2 in R
(Anders et al. 2015).

3.3 Differential Gene Expression and Pathway Analysis
3.3.1 Statistical Analyses with DESeq2
DESeq2(v3.5.2) in R was used for differential gene expression analysis. After
generating a gene count matrix for each condition, contrast arguments were constructed
to isolate pair-wise arguments within the gene matrix, and DESeq2 used statistical
techniques to moderate, or shrink, imprecise estimates toward zero. This avoids weakly
expressed genes showing stronger differences than those with strongly expressed genes
(Love et al. 2014). Differential expression was defined by a Benjamini-Hochberg (BH)
adjusted p-value of less than 0.05 (FDR ≤ 0.05) between at least a pair of conditions
(Chen et al. 2015; Benjamini and Hochberg 1995). The fold difference (FD) is defined
relative to the control cultures at 37°C and pH 6.95. For example, a gene with higher
expression in the 33°C and pH 6.70 cultures would have a positive fold difference, were
as a gene with lower expression in the 33°C and pH 6.70 cultures would have a negative
fold difference.
3.3.2 Gene Set Analysis
To match gene symbols and gene names with the unique gene identifiers, or
Entrez IDs, the Bioconductor package AnnotationDbi (v.146.0) was used. To import the
Chinese hamster annotation (CHOK1GS_HDv1) from the Ensembl database, the
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Bioconductor package AnnotationHub (v2.10.1) was used. Once mapped, the resulting
gene list included a list of gene symbols and gene names, as well as LOC genes that were
both characterized and not functionally characterized. Using this list of genes, the gene
ontology reference PANTHER (v14.1) was used to analyze the biological and molecular
pathways (Mi et al. 2018).
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3.4 Results and Discussion
To understand the transcriptomic differences of CHO cells when cultured at
reduced temperatures (33°C) compared to the standard temperatures (37°C), as well as
the effects of low pH of 6.70 compared to the control pH of 6.95, two different cells lines
were utilized: CHO K1-PF and rCHO DP-12. A recombinant and nonrecombinant cell
line were used to gain a better understanding of the impact of different culture
temperatures as well as the additional burden associated with recombinant protein
production. The cells were seeded at low cell concentrations into T flasks to avoid pH
shift during culturing. Additionally, the low seeding concentrations allowed for relatively
constant nutrient concentrations between the cultures. Figure 3.1 shows the experimental
design for this study, where four culture conditions were each conducted in duplicate for
both cell lines. The growth profiles are shown in Figure 3.2, where the sample times are
represented by black circles. The metabolite profiles for the 33°C and 37°C cultures are
shown in figure 3.3. The 37°C cultures were sampled at 48 hours, and the 33°C cultures
were samples at 72 hours to have similar cell concentrations and metabolite levels to the
37°C cultures. Table 3.1 shows the growth rates for the four culture conditions by cell
line. Both the 33°C and 37°C cultures had exponential growth for over 96 hours, and the
samples for RNA-Seq analysis were taken during mid exponential phase. As expected,
the growth rates for the 37°C cultures were higher than the 33°C cultures. Additionally,
the growth rates for the rCHO DP-12 cultures were significantly higher compared to the
CHO K1-PF cultures (p ≤ 0.05). However, the growth rates were not different between
cultures due to pH (p > 0.05).

24

Figure 3.1: Experimental design for CHO K1-PF and rCHO DP-12 cell lines. Four
culture conditions were each conducted in duplicate for both cell lines.
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Figure 3.2: Growth profiles for CHO K1-PF and rCHO DP-12 cultures. Cells were
cultured at 37°C and 33°C as well as pH 6.95 and pH 6.70. The black circles
indicate when RNA samples were taken, which were 48 hours for the 37°C cultures
and 72 hours for the 33°C cultures. Error bars represent standard deviation.
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Figure 3.3: Glucose and lactate profiles for CHO K1-PF and rCHO DP-12
cultures. Error bars represent standard deviation.
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Table 3.1: Effect of culture temperature and initial culture pH on growth rates for
CHO K1-PF and rCHO DP-12 cultures. The exponential growth rates with standard
deviations are shown. pH was not a significant factor (p > 0.05), while cell line and
temperature were significant factors (p ≤ 0.05).

Cell Line

Temperature

Initial Culture pH

37°C

33°C

6.95

0.029 ± 0.001

0.010 ± 0.0002

6.70

0.027 ± 0.002

0.009 ± 0.0004

6.95

0.034 ± 0.002

0.013 ± 0.002

6.70

0.034 ± 0.00002

0.014 ± 0.001

CHO K1-PF

rCHO DP-12
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3.5.1 Differential Gene Expression Analyses of both CHO cell lines
In order to determine if the culture temperature or pH had an effect on either cell
line, RNA was collected in parallel cultures in the mid-exponential phase. Specifically,
RNA was collected from samples with at least 2 X 105 cells/mL and greater than 95%
viability. Additionally, the glucose concentrations were above 5 g/L and lactate
concentrations were below 1 g/L, demonstrating the cells were not lactate inhibited. A
total of 26,125 genes with nonzero read counts were used for statistical analysis. A
multidimensional scaling (MDS) analysis in edgeR and a principle component analysis
(PCA) in DESeq2 were used to identify major causes of variance of gene expression
levels for different cell lines and culture conditions. The initial MDS plots identified that
both CHO K1-PF 37°C, pH 6.70 samples contained outliers. Further analysis confirmed
that these samples had been contaminated in the library preparation phase. Although the
original harvest RNA was free of contamination, there was insufficient RNA to repeat the
sequencing. The MDS plot with and without the CHO K1-PF 37°C, pH 6.70 samples are
shown in Appendix B-1. Since DESeq2 was the tool used in the current analysis, the PCA
plot of the remaining samples is shown in Figure 3.1, where PC1 represents 85% of the
variance and PC2 represents 11% of the variance. The PCA plot also indicates that pH
caused minimal variance between samples, since these samples were clustered very close
to each other (Figure 3.2).
Since the objective of this work was to determine the effects of temperature and
pH, and the PCA plots clearly show that cell line variance dominated, the statistical
analysis needed to be conducted for each cell line. If the statistical analysis grouped the
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cell lines together for temperature effects, the fact that each cell line had different
baseline levels for a particular gene confounded the analysis. Yet, most genes changed in
the same direction due to temperature for both cell lines. Table 3.2 shows the number of
genes with differential expression due to pH by cell line. The number of genes passing
the FDR due to pH are lower than the expected false positive number, which is in
agreement with the PCA plot and considered a type I error. Table 3.3 shows the number
of genes with differential expression due to culture temperature by cell line. The number
of genes passing the FDR criteria is higher than the expected false positive values for
both cell lines. Using the conventional FDR ≤ 0.05, there were 3241 temperaturesensitive genes in CHO K1-PF and 2936 temperature sensitive genes in rCHO DP-12
(Figure 3.4). Using the union of the FDR ≤ 0.05 and FD > 1.0 genes for both cell lines,
there were 4184 genes identified as temperature sensitive. Of the 4184 temperature
sensitive genes, 1993 genes were identified as significant in both cell lines (Figure 3.4).
For the 3241 temperature sensitive genes for CHO K1-PF, 471 genes had FDR ≤ 0.05
and FD ≥ 1.5 (Figure 3.5). For the 2936 temperature sensitive genes for rCHO DP-12,
185 genes had FDR ≤ 0.05 and FD ≥ 1.5 (Figure 3.6). The union of the FDR ≤ 0.05 and
FD ≥ 1.5 genes for both cell lines identified 553 genes (Figure 3.7). The 4184
temperature-sensitive genes for both cell lines were used to analyze the impact of
temperature on specific bioprocess related processes such as cold and heat shock, cell
cycle, glycosylation, and apoptosis related genes. Additionally, the 4184 temperature
sensitive genes were used for gene ontology enrichment analysis to identify common
control patterns in gene expression due to reduced culture temperature.
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Figure 3.4: Principle component analysis (PCA) of all culture conditions for each
cell line. PC1 represents 85% of the variance and PC2 represents 11% of the
variance.
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Table 3.2 Differentially expressed genes for CHO K1-PF and rCHO DP-12
between the cultures with initial pH 6.70 vs. pH 6.95. FDR represents FDR
adjusted p-value cutoffs.

Number of Genes
FDR Criteria

CHO K1-PF

rCHO DP-12

0.10

2152

195

0.05

1773

107

0.01

1237

43

Table 3.3 Differentially expressed genes for CHO K1-PF and rCHO DP-12 due to
temperature. FD represents the fold-difference between the 33°C cultures relative to
the 37°C cultures for each cell line. FDR represents FDR adjusted p-value cutoffs. The
numbers in bold represent the genes used for the data analysis, unless specified
otherwise.

Criteria

Number of Genes

FDR

FD

CHO K1-PF

rCHO DP-12

FDR ≤ 0.1

FD > 1.0

3775

3444

FDR ≤ 0.1

FD ≥ 1.5

524

213

FDR ≤ 0.05

FD > 1.0

3241

2936

FDR ≤ 0.05

FD ≥ 1.5

471

185

FDR ≤ 0.01

FD > 1.0

2528

2279

FDR ≤ 0.01

FD ≥ 1.5

362

122
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Figure 3.5: Venn diagram of temperature sensitive genes for CHO K1-PF and rCHO
DP-12 cultures. There were 3241 temperature sensitive genes for CHO K1-PF (dark
gray) and 2936 temperature sensitive genes for rCHO DP-12 (white) (FDR ≤ 0.05 and
FD > 1.0). There were a total of 4184 temperature sensitive genes with at least a 1.0fold difference in at least one cell line.
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Figure 3.6: Distribution of temperature sensitive genes for CHO K1-PF. There were a
total of 3241 temperature sensitive genes (FDR ≤ 0.05). Each group of genes is
separated into both fold differences (purple) and expression levels (orange). The total
temperature sensitive gene group is subdivided into genes with known and unknown
functions. Higher expression levels (darker orange) indicate higher gene expression in
colder culture temperatures (33°C) relative to the control (37°C). The fold differences
are structured into genes with less than 1.5-fold (darkest purple), at least 1.5-fold, but
less than 2-fold (middle purple) and at least 2-fold (light purple).
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Figure 3.7: Distribution of temperature sensitive genes for rCHO DP-12. There were a
total of 2936 temperature sensitive genes (FDR ≤ 0.05). Each group of genes are
separated into both fold differences (purple) and expression levels (orange). The total
temperature sensitive gene group is subdivided into genes with known and unknown
functions. Higher expression levels (darker orange) indicate higher gene expression in
colder culture temperatures (33°C) relative to the control (37°C). The fold differences
are structured into genes with less than 1.5-fold (darkest purple), at least 1.5-fold, but
less than 2-fold (middle purple) and at least 2-fold (light purple).
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Figure 3.8: Venn diagram of the temperature sensitive genes in CHO K1-PF and
rCHO DP-12 cultures with at least 1.5-fold differences. There were 471 differentially
expressed genes for CHO K1-PF (dark gray) and 185 differentially expressed genes
for rCHO DP-12 (white) (FD ≥ 1.5 and FDR ≤ 0.05). There were a total of 553
temperature sensitive genes with at least 1.5-fold difference.
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3.5.2 Heat & Cold Shock Related Genes
Sub-physiological temperatures can induce the synthesis of several cold-shock
proteins. In contrast, heat shock proteins were first observed under heat shock, but now
these classes of proteins are known to be regulated under many stresses (Lleonart 2010;
Sõti et al. 2009). The 4184 temperature-sensitive genes were used to identify heat or cold
shock-related genes by searching the gene descriptions. Three cold shock-related genes
were observed to have greater than 1.0-fold difference (Table 3.4), whereas two well
characterized cold shock genes, Rbm3 and Cirbp, had greater than 1.5-fold difference as
shown in Figure 3.9. Forty heat shock related genes for CHO K1-PF and 43 heat shock
related genes for rCHO DP-12 were identified with the temperature sensitive gene list
(Table 3.5). It was noted that most of the heat shock-related genes had lower expression
in the colder culture temperature (33°C) compared to 37°C.
Often the change observed for genes due to temperature shifts from 37°C to 34°C
or 28°C can range from 3.3 to 13.5-fold, whereas in this study, only 2.1 to 2.9-fold
differences were observed (Bedoya-López et al. 2016). Cirbp and Rbm3 are well
characterized cold shock proteins involved in binding mRNAs to help maintain mRNA
stability in sub-physiological temperatures. More specifically, Rbm3 is one of the bestknown proteins to facilitate translation during mild hypothermia (Masterton and Smales
2014; Gammell 2007). It was expected that Cirbp and Rbm3 genes would have higher
expression in the 33°C cultures compared to 37°C cultures. Protein disulphide isomerase
(Pdi) has also been reported as up regulated at low culture temperatures, which is an
enzyme in the endoplasmic reticulum that catalyzes the formation and breakage of
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disulfide bonds with proteins during protein folding (Gammell et al. 2007; Kumar et al.
2007). Interestingly, three Pdi family members had higher expression in CHO K1-PF,
while 2 Pdi family members had lower expression in rCHO DP-12 at lower culture
temperatures.
Heat shock proteins function as molecular chaperones, where these proteins
recognize and bind to other proteins that are in non-native conformations due to proteindenaturing stresses, such as changes of temperature. Then, they either assist in folding the
denatured proteins or degrade and remove them from the cell (Feder and Hodmann
2002). Of the few heat shock genes that had higher expression at 33°C compared to 37°C,
Hspd1 was the only HSP gene that met the FDR ≤ 0.05 and FD ≥ 1.5 criteria for both cell
lines. However, the lower expression at 33°C is comparable to the other heat shock gene
responses. Hspd1 is mainly located in the mitochondria and assists with folding
mitochondrial proteins. Hspd1 also has a direct role in apoptosis, where Hspd/Hspe can
promote caspase-3 activation (Samali et al 1999). While Hsbp1 only had a slight increase
in expression of 1.3-fold difference and Hspb1 had a slight decrease of 1.3-fold
difference in rCHO DP-12, both Hsbp1 and Hspb1 had higher expression at 33°C for
CHO K1-PF and met the FDR ≤ 0.05 and FD ≥ 1.5 criteria. However, these two genes
had relatively low expression levels compared to other HSP genes with similar function,
such that a major biological effect was unlikely. Most of the observed HSP genes were
observed to have FD ~ 1.3 to 1.4, suggesting that this might be the expected fold
difference mediated by the reduced temperature cultivation.
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Table 3.4: Cold shock-related genes that were identified as temperature-sensitive in at
least one of the cell lines (FDR ≤ 0.05). The gene expression fold-differences are shown
for the 33°C cultures relative to the 37°C cultures. Fold differences in bold indicate
Fold Difference
genes that met FDR ≤ 0.05 and FD ≥ 1.5 criteria.
Gene Symbol
Cirbp
Csde1
Pdia3
Pdia4
Pdia5
Pdia6
Pgk1
Rbm3

Gene Name
cold inducible RNA binding protein
cold shock domain containing E1
protein disulfide isomerase family A member 3
protein disulfide isomerase family A member 4
protein disulfide isomerase family A member 5
protein disulfide isomerase family A member 6
phosphoglycerate kinase 1
RNA binding motif protein 3
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CHO
K1-PF

rCHO
DP-12

2.2
-1.5
1.2

2.1
-1.2

2.2
1.2
-1.4
2.5

-1.3
-1.8
-1.2
2.9

Figure 3.9: Cold shock-related gene expression profiles for CHO K1-PF and rCHO
DP-12 cultured at 33°C and 37°C. Error bars represent one standard deviation. An
asterisk (*) indicates fold-differences were significant (FDR ≤ 0.05 and FD ≥ 1.5).
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Table 3.5: Heat shock-related genes that were identified as temperature-sensitive in at
least one of the cell lines (FDR ≤ 0.05). The gene expression fold-differences are shown
for the 33°C cultures relative to the 37°C cultures. Fold differences in bold indicate
genes that met FDR ≤ 0.05 and FD ≥ 1.5 criteria. Blanks indicate genes that did not
meet these criteria.

Fold Difference
Gene Symbol
Ahsa1
Cct2
Cct3
Cct4
Cct5
Cct6a
Cct7
Cct8
Dnaja1
Dnajb1
Dnajb11
Dnajb9
Dnajc2
Dnajc21
Dnajc22
Dnajc27
Dnajc30
Dnajc6
Dnajc9
Hsbp1
Hsp90aa1
Hsp90b1
Hspa4
Hspa8
Hspa9
Hspb1
Hspb6
Hspb8
Hspd1
Hsph1
LOC100753142
LOC100754792

Gene Name
activator of HSP90 ATPase activity 1
chaperonin containing TCP1 subunit 2
chaperonin containing TCP1 subunit 3
chaperonin containing TCP1 subunit 4
chaperonin containing TCP1 subunit 5
chaperonin containing TCP1 subunit 6A
chaperonin containing TCP1 subunit 7
chaperonin containing TCP1 subunit 8
DnaJ heat shock protein family (Hsp40) member A1
DnaJ heat shock protein family (Hsp40) member B1
DnaJ heat shock protein family (Hsp40) member B11
DnaJ heat shock protein family (Hsp40) member B9
DnaJ heat shock protein family (Hsp40) member C2
DnaJ heat shock protein family (Hsp40) member C21
DnaJ heat shock protein family (Hsp40) member C22
DnaJ heat shock protein family (Hsp40) member C27
DnaJ heat shock protein family (Hsp40) member C30
DnaJ heat shock protein family (Hsp40) member C6
DnaJ heat shock protein family (Hsp40) member C9
heat shock factor binding protein 1
heat shock protein 90 alpha family class A member 1
heat shock protein 90 beta family member 1
heat shock protein family A (Hsp70) member 4
heat shock protein family A (Hsp70) member 8
heat shock protein family A (Hsp70) member 9
heat shock protein family B (small) member 1
heat shock protein family B (small) member 6
heat shock protein family B (small) member 8
heat shock protein family D (Hsp60) member 1
heat shock protein family H (Hsp110) member 1
10 kDa heat shock protein, mitochondrial
heat shock protein HSP 90-beta
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CHO
K1-PF

rCHO
DP-12

-1.4
-1.3
-1.3
-1.4
-1.5
-1.5
-1.5
-2.1
-1.3
-1.2
1.2
1.4
-1.6
-1.3

-1.4
-1.2
-1.3
-1.3
-1.3
-1.4
-1.2

1.5
2.2
-1.6
2.9
-1.4
-1.3
-1.5
-1.3
2.2
1.3
-1.8
-1.7
-1.9
-1.3

-1.4
-1.3
-1.3
-1.3
-1.2
1.5
-1.5
1.3
-1.3
-1.2
-1.2
-1.5
-1.3
-1.3
-1.4
-1.1
-1.7
-1.6
-2.0
-1.4

Fold Difference
Gene Symbol
LOC100755978
LOC100762784
LOC100766036
LOC100766396
LOC100774172
Polr1a
Polr1c
Polr1d
Polr2a
Polr2c
Polr2f
Polr2h
Polr2k
Polr2l
Polr2m
Polr3d
St13

Gene Name
heat shock protein HSP 90-alpha pseudogene
60 kDa heat shock protein, mitochondrial pseudogene
10 kDa heat shock protein, mitochondrial
heat shock protein HSP 90-beta pseudogene
heat shock protein HSP 90-beta pseudogene
RNA polymerase I subunit A
RNA polymerase I and III subunit C
RNA polymerase I and III subunit D
RNA polymerase II subunit A
RNA polymerase II subunit C
RNA polymerase II subunit F
RNA polymerase II subunit H
RNA polymerase II subunit K
RNA polymerase II subunit L
RNA polymerase II subunit M
RNA polymerase III subunit D
ST13, Hsp70 interacting protein
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CHO
K1-PF

rCHO
DP-12

-1.4
-1.9
-2.1
-1.3
-1.4
-1.4
-1.5
-1.2
-1.3

-1.3
-1.5
-1.5
-1.3
-1.3
-1.4
-1.3
-1.4
-1.3
-1.1
-1.2
-1.3
-1.2

1.3
-1.4
-1.2

-1.3
-1.2

3.5.3 Cell Cycle Related Genes
The cell cycle is composed of four phases: G0/G1, S, G2, and M, where cell cycle
progression is regulated by complexes of cyclins and cyclin dependent kinases. Arrest of
the cell cycle at the G1/G0 phase is a common strategy used to increase protein
productivity in CHO cell cultures (Wolf et al 2019; Sunley 2008). In this study, the
effects of reduced culture temperature on cell cycle-related genes was investigated for
CHO K1-PF and rCHO DP-12. The 4184 temperature sensitive genes were compared to
the 312 cell cycle genes compiled by QIAGEN (https://www.qiagen.com/us/resources/).
It was observed that 116 cell cycle-related genes were temperature sensitive in at least
one of the cell lines (Table 3.6) (FDR ≤ 0.05). Most of the 116 cell cycle genes have
small fold differences and large FDR-values; however, 11 cell cycle genes have
significant differences with FDR ≤ 0.05 and FD ≥ 1.5.
For cell cycle-related genes, several cyclin genes had lower expression in the
33°C cultures. Specifically, four of the five cyclin related genes, Ccna2, Ccnb1, Ccnb2,
and Ccnf had lower expression levels in the 33°C cultures, even if not always significant
for both cell lines (Figure 3.14). Cyclin A2 (Ccna2) accumulates at the G1/S phase
transition, where cyclin-A associated kinase activity is required for entry into S phase and
M phase. For cells to exit mitosis, cyclin A and cyclins B (Ccnb1 and Ccnb2) must be
degraded, and studies have shown that cyclin B/cdk1 kinases participate in the regulation
of this destruction process. The lower expression levels of these cyclin genes agrees with
the observed lower growth rates (Johnson and Walker 1999). Ccng1, however, had higher
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expression in both cell lines. Ccng1, or cyclin G1, has been shown to have intrinsic
growth inhibitory activity, which would explain the observed higher expression levels in
colder culture conditions (Zhao et al. 2003). The cell division cycle genes that were
observed to have significantly lower expression in the 33°C cultures for CHO K1-PF
were Cdc25b, Ccdc6 and Cdca8. These genes, as well as Cdc7, Cdc23, and Cdc73, all
had lower expression in both cell lines. It is very clear that these genes have a
coordinated response due to temperature (Figure 3.15). Cdc25 phosphatases activate
complexes of cyclins and cyclin-dependent kinases (cdks) which then regulate cell cycle
transitions. Cdc25b, for example, regulates the G2-M phase of the cell cycle (Lee et al
2013; Ferguson et al 2005).
Aurora kinases, like Aurora kinase A (Aurka), are serine/threonine kinases
required for the control of mitosis. Aurka was found to have lower expression in both cell
lines. Since the function of Aurka is to coordinate centrosome maturation and
chromosome separation, lower expression could indicate hindering of cell cycle
progression in reduced culture conditions. Btg2, an anti-proliferation factor gene, had
significant increased expression levels for both cell lines. The protein encoded by Btg2 is
involved in the regulation of the G1/S transition of the cell cycle. This transition is a
critical restriction point in the mammalian cell cycle, where cells respond actively to a
decrease in culture temperatures by halting cell-cycle progression at this boundary prior
to DNA replication (Wolf et al 2019; Kaufmann 1998).
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Table 3.6: Cell cycle-related genes that were identified as temperature-sensitive in at
least one of the cell lines (FDR ≤ 0.05). The gene expression fold-differences are shown
for the 33°C cultures relative to the 37°C cultures. Fold differences in bold indicate
genes that met FDR ≤ 0.05 and FD ≥ 1.5 criteria. Blanks indicate genes that did not meet
these criteria.

Fold Differences
Gene
Symbol
Anapc7
Anp32e
Aspm
Atr
Aurka
Aurkb
Bccip
Brca2
Bub3
Calm1
Ccdc86
Ccna2
Ccnb1
Ccnb2
Ccnd2
Ccne1
Ccnf
Ccng1
Ccng2
Ccnh
Ccni
Ccnk
Cct5
Cd320
Cdc6
Cdc7
Cdc23
Cdc25a
Cdc25b
Cdc73
Cdca5
Cdca8

Gene Name
anaphase promoting complex subunit 7
acidic nuclear phosphoprotein 32 family member E
abnormal spindle microtubule assembly
ATR serine/threonine kinase
aurora kinase A
aurora kinase B
BRCA2 and CDKN1A interacting protein
BRCA2, DNA repair associated
BUB3, mitotic checkpoint protein
calmodulin 1
coiled-coil domain containing 86
cyclin A2
cyclin B1
cyclin B2
cyclin D2
cyclin E1
cyclin F
cyclin G1
cyclin G2
cyclin H
cyclin I
cyclin K
chaperonin containing TCP1 subunit 5
CD320 molecule
cell division cycle 6
cell division cycle 7
cell division cycle 23
cell division cycle 25A
cell division cycle 25B
cell division cycle 73
cell division cycle associated 5
cell division cycle associated 8
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CHO
K1-PF

rCHO
DP-12

-1.2
-1.5
-2.2
-1.5
-2.3
-2.6
-1.4
-1.8
-1.2
-1.2
1.2
-2.6
-2.6
-2.1
1.6

-1.2
-1.3
-1.3
-1.5
-1.7
-1.6
-1.3

-2.5
2.7

-1.2
-1.1
-1.6
-1.8
-1.4
-1.2
-1.3
-1.5
3.0
3.5

-1.2
1.4
-1.5
-2.3
-1.3
-1.2
-1.6
-2.6
-1.3
-1.6
-2.2

-1.3
-1.3
-1.5
-1.8
-1.3
-1.2
-1.4
-1.8
-1.2
-1.5
-1.5

Fold Differences
Gene
Symbol
Cdh1
Cdk2
Cdk4
Cdk5
Cdk9
Cdkn1b
Cdkn2a
Cdkn2c
Cenpe
Cenph
Cfl1
Chaf1b
Ckap2
Cks1b
Cks2
Cse1l
Ctnnal1
Dbf4
Dbi
Dtymk
Ebp
Eef1e1
Fbl
Fbxo5
Flnb
Gapdh
Gins2
Gmnn
Gsto1
Hmmr
Hprt1
Hspd1
Kif20a
Kif23
Kif4a
Kifc1
Mad1l1
Mad2l1
Mcm2
Mdm2

Gene Name
cadherin 1
cyclin dependent kinase 2
cyclin dependent kinase 4
cyclin dependent kinase 5
cyclin dependent kinase 9
cyclin dependent kinase inhibitor 1B
cyclin dependent kinase inhibitor 2A
cyclin dependent kinase inhibitor 2C
centromere protein E
centromere protein H
cofilin 1
chromatin assembly factor 1 subunit B
cytoskeleton associated protein 2
CDC28 protein kinase regulatory subunit 1B
CDC28 protein kinase regulatory subunit 2
chromosome segregation 1 like
catenin alpha like 1
DBF4 zinc finger
diazepam binding inhibitor, acyl-CoA binding protein
deoxythymidylate kinase
EBP, cholestenol delta-isomerase
eukaryotic translation elongation factor 1 epsilon 1
fibrillarin
F-box protein 5
filamin B
glyceraldehyde-3-phosphate dehydrogenase
GINS complex subunit 2
geminin, DNA replication inhibitor
glutathione S-transferase omega 1
hyaluronan mediated motility receptor
hypoxanthine phosphoribosyltransferase 1
heat shock protein family D (Hsp60) member 1
kinesin family member 20A
kinesin family member 23
kinesin family member 4A
kinesin family member C1
mitotic arrest deficient 1 like 1
mitotic arrest deficient 2 like 1
minichromosome maintenance complex component 2
MDM2 proto-oncogene
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CHO
K1-PF

1.7
-1.5
-1.1
1.4
-1.3
-2.6
-2.1
-1.4
-1.2
-1.3
-1.5
-2.3
-2.8
-2.0
-2.2
-1.2
-1.7
-1.8
-1.4
-1.6
-2.4
1.3
-1.3
-1.4
-1.9
1.7
-2.0
1.3
-1.8
-2.1
-2.1
-2.2
-4.0
-1.5
-2.0
-1.6
4.0

rCHO
DP-12

-1.3
-1.2
-1.1
-1.3
1.2
-1.4
-1.1
-2.8
-1.5
-1.7
-1.2
-1.5
-1.1
-1.5
-1.3
-1.4
-1.5
-1.6
-1.2
-1.3
-1.7
-1.5
-1.5
-1.7
-1.4
-1.5
-1.4
-1.1
-1.5
-1.3

Fold Differences
Gene
Symbol
Mnd1
Mrpl35
Mrps28
Mrto4
Myh10
Ncapg
Ndc80
Nek2
Pa2g4
Pfn1
Plk1
Ppp2r1b
Ppp2r5d
Prdx6
Prkca
Psmb6
Rad21
Rad51
Rad52
Rad54l
Rb1
Rbbp4
Rock2
Rrm2
Scara3
Slc25a5
Smc1a
Snrpa1
Snrpd1
Snrpd3
Snrpg
Spag5
Spc24
Stag1
Tipin
Tk1
Top2a
Tp53
Trip13
Tuba1c

Gene Name
meiotic nuclear divisions 1
mitochondrial ribosomal protein L35
mitochondrial ribosomal protein S28
MRT4 homolog, ribosome maturation factor
myosin heavy chain 10
non-SMC condensin I complex subunit G
NDC80, kinetochore complex component
NIMA related kinase 2
proliferation-associated 2G4
profilin 1
polo like kinase 1
protein phosphatase 2 scaffold subunit Abeta
protein phosphatase 2 regulatory subunit B'delta
peroxiredoxin 6
protein kinase C alpha
proteasome subunit beta 6
RAD21 cohesin complex component
RAD51 recombinase
RAD52 homolog, DNA repair protein
RAD54 like
RB transcriptional corepressor 1
RB binding protein 4, chromatin remodeling factor
Rho associated coiled-coil containing protein kinase 2
ribonucleotide reductase regulatory subunit M2
scavenger receptor class A member 3
solute carrier family 25 member 5
structural maintenance of chromosomes 1A
small nuclear ribonucleoprotein polypeptide A'
small nuclear ribonucleoprotein D1 polypeptide
small nuclear ribonucleoprotein D3 polypeptide
small nuclear ribonucleoprotein polypeptide G
sperm associated antigen 5
SPC24, NDC80 kinetochore complex component
stromal antigen 1
TIMELESS interacting protein
thymidine kinase 1, soluble
DNA topoisomerase II alpha
tumor protein p53
thyroid hormone receptor interactor 13
tubulin, alpha 1C
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CHO
K1-PF

rCHO
DP-12

-2.1

-1.4
-1.2
-1.3
-1.3
-1.4
-1.7

-1.7
-1.3
-1.9
-2.7
-2.1
-1.5
-1.3
-2.5
-1.5
-1.5
-1.3
-1.8
-1.5
-1.8
-1.4
-2.0
-1.3
-2.4
-1.4
1.4
-1.3
-1.7
-1.7
-1.4
-1.2
-2.1
-1.7
-1.7
-1.5
1.6
-2.2
-1.8
-1.3

-1.4
-1.4
-1.3
-1.3
-1.6
-1.2
-1.2
-1.1
-1.2
-1.2
-1.4
-1.5
1.2
-1.8
-1.3
-1.2
1.3
-1.3
-1.5
-1.2
-1.3
-1.2
-1.7
-1.2
-1.3
1.4
-1.3
-1.5
-1.4

Fold Differences
Gene
Symbol
Tyms
Ube2c
Ube2s
Uck2
Vamp8
Wee1
Zw10
Zwint

Gene Name
thymidylate synthetase
ubiquitin conjugating enzyme E2 C
ubiquitin conjugating enzyme E2 S
uridine-cytidine kinase 2
vesicle associated membrane protein 8
WEE1 G2 checkpoint kinase
zw10 kinetochore protein
ZW10 interacting kinetochore protein
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CHO
K1-PF

-1.3
-3.0
-1.9
-1.5
1.7
-1.7
-1.3
-2.0

rCHO
DP-12

-1.5
-1.8
-1.4
-1.5
1.3
-1.4

Figure 3.10: Cyclin gene expression profiles for CHO K1-PF and rCHO DP-12
cultured at 33°C and 37°C. Error bars represent one standard deviation. An
asterisk (*) indicates fold-differences were significant (FDR ≤ 0.05 and FD ≥ 1.5).
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Figure 3.11: Cell division-related gene expression profiles for CHO K1-PF and rCHO
DP-12 cultured at 33°C and 37°C. Error bars represent one standard deviation. An
asterisk (*) indicates fold-differences were significant (FDR ≤ 0.05 and FD ≥ 1.5).
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3.5.4 Glycosylation Related Genes
Glycosylation is vital for the efficacy of therapeutic glycoproteins. As production
yields continue to increase to meet growing therapy demands, the impact of the cell
culture process on glycosylation patterns is critical (Fung Wong et al. 2004). Factors that
influence the degree of glycosylation include culture media, culture pH, nutrient levels,
waste product levels, and culture temperature. Reducing the culture temperature has been
observed to improve glycosylation profiles and product quality of recombinant proteins
(Wong et al 2009; Gupta and Shukla 2018; Yamane-Phnuki & Satoh 2009). In this study,
the effects of culturing cells at 33°C vs 37°C on glycosylation-related gene expression
was examined for two CHO cell lines: CHO K1-PF and rCHO DP-12. The 4184
temperature sensitive genes were compared to the 298 glycosylation-related genes
obtained from Xu et al. (2011). It was observed that 63 glycosylation-related genes were
temperature sensitive in at least one of the cell lines (Table 3.7) (FDR ≤ 0.05). Most of
the identified 63 genes had small fold-differences due to temperature and large FDRvalues; however, 13 glycosylation genes had significant differences with FDR ≤ 0.05 and
FD ≥ 1.5.
Neu1 and Neu2 are two of four sialidases responsible for the removal of the sialic
acid content of glycoproteins. Sialic acids are a critical quality attribute that affects invivo activity, circulation longevity, and ultimately the efficacy of glycoprotein
therapeutics (Xu 2011; Yin et a. 2017). In the 33°C cultures, it was observed that Neu2
had significantly lower expression in both cell lines, while Neu1 only had significantly
higher expression in CHO K1-PF. Figure 3.12 shows that both Neu1 and Neu2 had
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similar responses to colder culture temperatures between CHO K1-PF and rCHO DP-12
cell lines. Neu1 also had much higher basal expression levels than Neu2 and Neu3 even
though it was observed to be expressed in both cell lines, while Neu4 expression was not
observed in either cell line (Figure 3.12). Neu1 functions to remove sialic acid on Nglycan residues and could have higher activity in lower culture temperatures (Tejwani et
al. 2018).
Solute carrier family members function as nucleotide sugar transporters, which
translocate nucleotide substrates for glycosylation from the cytosol, where they are
mainly synthesized, into the lumen of the golgi apparatus (Berninsone and Hirschberg
1998). Figures 3.13 and 3.14 show MA plots of 4 solute carrier family members, which
transforms data onto M (log ratio) and A (mean count averages) scale, for both cell lines.
It was observed that Slc35a1, Slc35b1, and Slc35d1 had higher expression for both cell
lines, while Slc35e1 had lower expression at the lower culture temperatures. Slc35d1 had
significant differences in expression with FDR ≤ 0.05 and FD ≥ 1.5 for both cell lines. It
was also noted that there were no major changes of sialyltransferase enzyme levels, such
as galactosyltransferases.

52

Table 3.7: Glycosylation-related genes that were identified as temperature-sensitive
in at least one of the cell lines (FDR ≤ 0.05). The gene expression fold-differences
are shown for the 33°C cultures relative to the 37°C cultures. Fold differences in
bold indicate genes that met FDR ≤ 0.05 and FD ≥ 1.5 criteria. Blanks indicate
genes that did not meet these criteria.

Fold Differences
Gene
Symbol
Aga
Alg11
Arsa
B3galt6
B3gat3
B4galt2
B4galt3
B4galt4
B4galt5
C1galt1c1
Chst14
Chst2
Chsy1
Ctbs
Ctsa
Dpm3
Ext1
Fuca1
Fut11
Galnt7
Gba
Gm2a
Gmppb
Gnb1
Gne
Gns
Hpse
Hs6st1
Hs6st3
Hyal1
Idua
Lipa
Man1a1

Gene Name
aspartylglucosaminidase
ALG11, alpha-1,2-mannosyltransferase
arylsulfatase A
beta-1,3-galactosyltransferase 6
beta-1,3-glucuronyltransferase 3
beta-1,4-galactosyltransferase 2
beta-1,4-galactosyltransferase 3
beta-1,4-galactosyltransferase 4
beta-1,4-galactosyltransferase 5
C1GALT1 specific chaperone 1
carbohydrate sulfotransferase 14
carbohydrate sulfotransferase 2
chondroitin sulfate synthase 1
chitobiase
cathepsin A
dolichyl-phosphate mannosyltransferase subunit 3
exostosin glycosyltransferase 1
alpha-L-fucosidase 1
fucosyltransferase 11
polypeptide N-acetylgalactosaminyltransferase 7
glucosylceramidase beta
GM2 ganglioside activator
GDP-mannose pyrophosphorylase B
G protein subunit beta 1
glucosamine (UDP-N-acetyl)-2-epimerase/Nacetylmannosamine kinase
glucosamine (N-acetyl)-6-sulfatase
heparanase
heparan sulfate 6-O-sulfotransferase 1
heparan sulfate 6-O-sulfotransferase 3
hyaluronidase 1
iduronidase, alpha-Llipase A, lysosomal acid type
mannosidase alpha class 1A member 1
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CHO
K1-PF

rCHO
DP-12

-1.1
-1.2
2.4
1.4
1.3
-1.3

1.1
-1.5
1.3

1.5
1.4
1.4
-1.4
1.8
1.6
1.7

1.3
1.2
1.4
-1.3
1.3
1.1
1.2

1.7
-1.4
2.1
1.6
1.6
-1.1

-1.5
1.8
1.5
1.2
1.3

1.3

1.3

1.5
1.4
-1.3

1.4
1.5
4.2

1.9
2.1
1.6

1.3
3.1

Fold Differences
Gene
Symbol
Man1a2
Man1c1
Man2a1
Man2b1
Naga
Naglu
Nans
Neu1
Neu2
Neu3
Pgm1
Pomt2
Rpn1
Slc35a1
Slc35a2
Slc35a3
Slc35b4
Slc35c1
Slc35d1
Slc35e1
Slc35e3
St3gal2
St3gal4
St8sia6
Sulf2
Tsta3
Ugcg
Ugp2
Ust
Xylt2

Gene Name
mannosidase alpha class 1A member 2
mannosidase alpha class 1C member 1
mannosidase alpha class 2A member 1
mannosidase alpha class 2B member 1
alpha-N-acetylgalactosaminidase
N-acetyl-alpha-glucosaminidase
N-acetylneuraminate synthase
neuraminidase 1
neuraminidase 2
neuraminidase 3
phosphoglucomutase 1
protein O-mannosyltransferase 2
ribophorin I
solute carrier family 35 member A1
solute carrier family 35 member A2
solute carrier family 35 member A3
solute carrier family 35 member B4
solute carrier family 35 member C1
solute carrier family 35 member D1
solute carrier family 35 member E1
solute carrier family 35 member E3
ST3 beta-galactoside alpha-2,3-sialyltransferase 2
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
ST8 alpha-N-acetyl-neuraminide alpha-2,8sialyltransferase 6
sulfatase 2
tissue specific transplantation antigen P35B
UDP-glucose ceramide glucosyltransferase
UDP-glucose pyrophosphorylase 2
uronyl 2-sulfotransferase
xylosyltransferase 2
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CHO
K1-PF

-1.2
-1.4
1.5
1.6
1.7
2.3
2.4
-3.2
1.8
1.2
1.4
1.4
1.8
1.3
-1.3
1.9
-1.3
1.4
-1.3

rCHO
DP-12

1.2
1.5
1.6
-1.2
1.7
-3.7
1.1
-1.2
1.2
1.3
-1.2
2.0
-1.2
1.3
1.2

3.3
70.9
2.0
2.1
-1.4
1.4

8.6
1.5
1.5
1.3
-1.2
1.4

Figure 3.12: Sialidase gene expression profiles for CHO K1-PF and rCHO DP-12
cultured at 33°C and 37°C. Error bars represent one standard deviation. An
asterisk (*) indicates fold-differences were significant due to reduced temperature
(FDR ≤ 0.05 and FD ≥ 1.5).
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Figure 3.13: MA plot of all genes in CHO K1-PF (FDR ≤ 0.05). Fold differences are
positive for genes with higher expression at 33°C relative to 37°C. Data in red
indicates temperature sensitive genes with FD > 1.0. The four circled genes are
glycosylation related genes.
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Figure 3.14: MA plot of all genes in rCHO DP-12 (FDR ≤ 0.05). Fold differences
are positive for genes with higher expression at 33°C relative to 37°C. Data in red
indicates temperature sensitive genes with FD > 1.0. The four circles genes are
glycosylation related genes.
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3.5.5 Apoptosis Related Genes
In bioprocessing, cell death is a major barrier to maintain high cell densities and
increase protein yields. One approach to delay cell death is through anti-apoptosis
engineering. Apoptosis-resistant CHO cell lines have been developed by overexpression
of anti-apoptotic proteins or lowering the expression of apoptotic proteins (Wong et al.
2005, Kim et al. 2012). To screen genes for potential cell engineering selection,
transcriptomic studies are fundamental to correlate apoptosis to different culture
conditions. In this study, the effects of the reduced culture temperature on apoptosisrelated genes was investigated for CHO K1-PF and rCHO DP-12. The 4184 temperaturesensitive genes were compared to the 532 apoptosis-related gene list compiled by
QIAGEN (https://www.qiagen.com/us/resources/). It was observed that 126 apoptosisrelated genes were temperature sensitive in at least one of the cell lines (Table 3.8) (FDR
≤ 0.05). Most of the 126 genes had small fold differences and large FDR-values;
however, 14 apoptosis-related genes had significant differences with FDR ≤ 0.05 and FD
≥ 1.5.
Early events in apoptosis had no significant gene expression changes.
Bid, Bax, and Bak1 expression levels, which are important pro-apoptotic genes in the
apoptosis cascade and upstream of cytochrome c release from the mitochondria, are
shown in Figure 3.15. Bax, a gene that encodes a Bcl-2 family protein, had significantly
higher gene expression in both cell lines at 33°C. While Bax is found in the cytosol in
healthy cells, it is translocated to the mitochondria upon induction of apoptosis, where it
is directly involved in mitochondria dysfunction and cytochrome c release (Lim et al
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2006, Arden and Betenbaugh 2004). Bid had higher expression in lower culture
temperatures, while Bak1 had slightly lower expression in both cell lines. Caspase family
genes are known to be involved in apoptotic cell death. Casp3 was observed to have
significantly higher gene expression at 33°C compared to 37°C for rCHO DP-12, while
Casp6 was observed to have significantly higher expression for CHO K1-PF (Figure
3.15). Caspases 3 and 6 are downstream effector classes of caspases, where activation of
these caspases leads to the final execution of cell death (Mohan et al 2008; Arden and
Betenbaugh 2004). Casp8, which functions to drive cell-extrinsic apoptosis when
activated, had decreased expression at 33°C, but this decrease was not significant
(Mandal et al. 2014). Additionally, Casp1, Casp4, Casp7, and Casp10 expression was not
observed in either cell line (Figure 3.15).
Anti-apoptotic genes Mcl1, Bcl2, Akt1, and Akt2 are shown in Figure 3.16. Mcl1
had lower expression in CHO K1-PF but had higher expression in rCHO DP-12. Similar
to proapoptotic genes, there was not a coordinated response in anti-apoptotic gene
expression due to temperature. Overall, the concept of suppressed apoptosis levels at
reduced temperatures was not observed in this study for either cell line. Specifically, no
observations of higher anti-apoptotic gene expression in either cell line contradicts
reports of other CHO cell transcriptome studies assessing the impacts of reducing culture
temperatures (Bedoya-López et al. 2016; Tossolini et al. 2018)
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Table 3.8: Apoptosis-related genes that were identified as temperature sensitive in at
least one of the cell lines (FDR ≤ 0.05). The gene expression fold-differences are shown
for the 33°C cultures relative to the 37°C cultures. Fold differences in bold indicate
genes that met FDR ≤ 0.05 and FD > 1.5 criteria. Blanks indicate genes that did not meet
these criteria.

Fold Differences
Gene
Symbol
Aatf
Adam17
Aifm1
Akt1
Akt2
Angptl4
Apex1
Arid4a
Aven
Bag4
Bak1
Bard1
Bax
Bcl10
Bcl2l1
Bid
Bnip1
Capn1
Capn11
Capn6
Card6
Casp2
Casp3
Casp6
Casp8
Cav1
Cav2
Cbl
Cd28
Cdc25a
Cdkn2a
Cse1l
Ctnnal1
Ctsd

Gene Name
apoptosis antagonizing transcription factor
ADAM metallopeptidase domain 17
apoptosis inducing factor mitochondria associated 1
AKT serine/threonine kinase 1
AKT serine/threonine kinase 2
angiopoietin like 4
apurinic/apyrimidinic endodeoxyribonuclease 1
AT-rich interaction domain 4A
apoptosis and caspase activation inhibitor
BCL2 associated athanogene 4
BCL2 antagonist/killer 1
BRCA1 associated RING domain 1
BCL2 associated X, apoptosis regulator
B cell CLL/lymphoma 10
BCL2 like 1
BH3 interacting domain death agonist
BCL2 interacting protein 1
calpain 1
calpain 11
calpain 6
caspase recruitment domain family member 6
caspase 2
caspase 3, apoptosis-related cysteine peptidase
caspase 6
caspase 8
caveolin 1
caveolin 2
Cbl proto-oncogene
CD28 molecule
cell division cycle 25A
cyclin dependent kinase inhibitor 2A
chromosome segregation 1 like
catenin alpha like 1
cathepsin D
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CHO
K1-FP

rCHO
DP-12

-1.3
1.3

-1.2
-1.2

-1.3
1.3
3.3
-1.2
-1.4
-1.2
-1.4
-3.0
2.2
-1.2
1.4
1.3
-1.7
1.2
4.3
3.9
1.7
-1.4
1.8
2.4
-1.4
1.2
-1.2
-1.2
-1.7
-1.6
-2.8
-2.0
1.8

-1.3
-1.3
-1.2
-1.2
-1.3
-1.6
2.1
-1.3
1.2
1.5
1.7
2.1
1.8
-1.2
1.2
-4.0
-1.4
1.2
-1.2
1.2

Fold Differences
Gene
Symbol
Dapk1
Ddx41
Dffa
Diablo
Dnase1
Dnase1l3
Dnase2
Dusp6
Dusp7
E2f1
Ei24
Eif4g2
Emp1
Emp2
Emp3
Enc1
Ercc3
F2r
Fadd
Faf1
Fem1b
Fosl2
Foxk2
Gpx1
Gpx4
Gsk3b
Gsto1
Gstp1
Hsp90b1
Htra2
Ier3
Igfbp4
Ikbkg
Il10
Junb
Lgals1
Litaf
Mageh1
Map2k1

Gene Name
death associated protein kinase 1
DEAD-box helicase 41
DNA fragmentation factor subunit alpha
diablo IAP-binding mitochondrial protein
deoxyribonuclease 1
deoxyribonuclease 1 like 3
deoxyribonuclease 2, lysosomal
dual specificity phosphatase 6
dual specificity phosphatase 7
E2F transcription factor 1
EI24, autophagy associated transmembrane protein
eukaryotic translation initiation factor 4 gamma 2
epithelial membrane protein 1
epithelial membrane protein 2
epithelial membrane protein 3
ectodermal-neural cortex 1
ERCC excision repair 3, TFIIH core complex helicase
subunit
coagulation factor II thrombin receptor
Fas associated via death domain
Fas associated factor 1
fem-1 homolog B
FOS like 2, AP-1 transcription factor subunit
forkhead box K2
glutathione peroxidase 1
glutathione peroxidase 4
glycogen synthase kinase 3 beta
glutathione S-transferase omega 1
glutathione S-transferase, pi 1
heat shock protein 90 beta family member 1
HtrA serine peptidase 2
immediate early response 3
insulin like growth factor binding protein 4
inhibitor of nuclear factor kappa B kinase subunit gamma
interleukin 10
JunB proto-oncogene, AP-1 transcription factor subunit
galectin 1
lipopolysaccharide induced TNF factor
MAGE family member H1
mitogen-activated protein kinase kinase 1
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CHO
K1-FP

rCHO
DP-12

2.8

1.8
-1.2
1.7
-1.2

1.5
-1.3
41.6
2.1
1.6
-1.8
-1.4
1.6
-1.5
-1.5
1.6
-1.3
2.5

1.3
-1.6
-1.8
1.3
-1.2
1.4
1.5
-1.1

1.9
-1.5
-1.5
-1.5
-1.2
1.7
1.3
2.7
1.7

1.5
1.2
1.4
-1.4

1.4
-1.3
-1.1
-1.2
1.3
1.2
-1.5
-1.2
-1.2
-1.4
-1.6
1.2
-3.7
-1.8
1.1
1.3
1.2

Fold Differences
Gene
Symbol
Mapk1
Mcl1
Mdm2
Mmd
Mrps30
Ndufa13
Nfkbia
Nfkbie
Nod2
Nrg2
Nupr1
Pak1
Parp1
Pawr
Pdcd4
Pdcd5
Phlda2
Pik3c2g
Pml
Ppm1f
Ppp2r1b
Prkca
Pten
Ptgs2
Rad21
Rad23b
Raf1
Rb1
Rbbp4
Rbl1
Rbl2
Rhob
Ripk2
Scarb1
Serpinb2
Sod1
Tdgf1
Tgfb1
Tlr2

Gene Name
mitogen-activated protein kinase 1
MCL1, BCL2 family apoptosis regulator
MDM2 proto-oncogene
monocyte to macrophage differentiation associated
mitochondrial ribosomal protein S30
NADH:ubiquinone oxidoreductase subunit A13
NFKB inhibitor alpha
NFKB inhibitor epsilon
nucleotide binding oligomerization domain containing 2
neuregulin 2
nuclear protein 1, transcriptional regulator
p21 (RAC1) activated kinase 1
poly(ADP-ribose) polymerase 1
pro-apoptotic WT1 regulator
programmed cell death 4
programmed cell death 5
pleckstrin homology like domain family A member 2
phosphatidylinositol-4-phosphate 3-kinase catalytic
subunit type 2 gamma
promyelocytic leukemia
protein phosphatase, Mg2+/Mn2+ dependent 1F
protein phosphatase 2 scaffold subunit Abeta
protein kinase C alpha
phosphatase and tensin homolog
prostaglandin-endoperoxide synthase 2
RAD21 cohesin complex component
RAD23 homolog B, nucleotide excision repair protein
Raf-1 proto-oncogene, serine/threonine kinase
RB transcriptional corepressor 1
RB binding protein 4, chromatin remodeling factor
RB transcriptional corepressor like 1
RB transcriptional corepressor like 2
ras homolog family member B
receptor interacting serine/threonine kinase 2
scavenger receptor class B member 1
serpin family B member 2
superoxide dismutase 1
teratocarcinoma-derived growth factor 1
transforming growth factor beta 1
toll like receptor 2
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CHO
K1-FP

rCHO
DP-12

-1.3
1.2
4.0
2.2
-1.2
1.2
1.2
1.5
2.3
-2.8
2.4
3.0
-1.6
-1.6
8.4
-1.3
34.2

-1.5
1.4
-4.0
1.8
-1.4
-1.4
-1.2
-2.8

-1.5
-1.8
-1.5
-1.3
-1.2
-1.3
-1.4
1.6

1.4
1.1
-1.2
2.9
-1.6
-1.2
-1.2
1.2
-1.3
-1.2
1.4
1.4

-2.0
-1.1
-8.5
-1.2
2.3
-1.3
2.4

-1.2
1.7
-1.7

Fold Differences
Gene
Symbol
Tnfrsf12a
Tnfrsf1b
Tnfsf4
Tnfsf9
Tp53
Traf4
Traip
Txnl1
Vdac1
Wdr3
Ywhab
Ywhah
Ywhaq
Ywhaz

Gene Name
TNF receptor superfamily member 12A
TNF receptor superfamily member 1B
TNF superfamily member 4
TNF superfamily member 9
tumor protein p53
TNF receptor associated factor 4
TRAF interacting protein
thioredoxin like 1
voltage dependent anion channel 1
WD repeat domain 3
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
activation protein beta
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
activation protein eta
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
activation protein theta
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
activation protein zeta
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CHO
K1-FP

rCHO
DP-12

-1.5
-1.2
4.8
1.6

-1.7
1.2

1.3
-2.2
-1.2
-1.3
-1.2

-1.5
-1.3
-1.2
-1.6
-1.1
-1.3

-1.1
-1.3

-1.3

-1.2

-1.1

-1.3

-1.1

Figure 3.15: Pro-apoptotic gene expression profiles for CHO K1-PF and rCHO
DP-12 cultured at 33°C and 37°C. Error bars represent one standard deviation. An
asterisk (*) indicated fold-differences were significant (FDR ≤ 0.05 and FD ≥ 1.5).
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Figure 3.16: Anti-apoptotic gene expression profiles for CHO K1-PF and rCHO
DP-12 cultured at 33°C and 37°C. Error bars represent one standard deviation
(FDR ≤ 0.05).
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3.5.6 Gene Ontology
To further understand the types of biological processes affected by culture
temperature, a gene ontology (GO) enrichment analysis was conducted using the
PANTHER database (Muruganujan et al. 2019). GO analysis was performed using the
identified 4184 temperature-sensitive genes for CHO K1-PF and rCHO DP-12. 2939
genes had unique GO terms (FDR ≤ 0.05). A PANTHER statistical enrichment test was
used on the gene set, where biological processes with GO terms were used for further
analysis (FDR ≤ 0.05). Specific GO categories were then identified, such as Cell Cycle
DNA Replication (GO:0044786), Tricarboxylic Acid (GO:0006099) and Glycolytic
Process (GO:0006096), where genes in each category were investigated to assess if any
coordinated response in gene expression were found for both cell lines.
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Figure 3.17: DNA replication-associated GO terms for the temperature
sensitive genes for CHO K1-PF and rCHO DP-12 (FDR ≤ 0.05).
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Figure 3.18: Metabolic process-associated GO terms for the temperature
sensitive genes for CHO K1-PF and rCHO DP-12 (FDR ≤ 0.05).

68

Figure 3.19: Positive response to cold-associated GO terms for the
temperature sensitive genes for CHO K1-PF and rCHO DP-12 (FDR ≤ 0.05).
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Figure 3.20: Metabolic pathway-associated GO terms for the temperature
sensitive genes for CHO K1-PF and rCHO DP-12 (FDR ≤ 0.05).
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Cell Cycle DNA Replication and DNA Replication Initiation GO terms are found in
Figure 3.17. The 11 genes in Cell Cycle DNA Replication all had lower expression at
reduced culture temperatures for both cell lines. Cdc45, for instance, is required for both
initiation and elongation of DNA replication, and lower expression could indicate a
reduced cell growth rate at 33°C (Gambus et al. 2006). Additionally, genes in the GO
category DNA Replication Initiation had lower expression for a majority of both CHO
K1-PF and rCHO DP-12 genes at 33°C. Specifically, 14 of the 21 genes in this category
were enriched, where 10 of the 14 genes had over 1.5-fold difference in either or both cell
lines. The initiation of DNA synthesis in mammalian cells, like CHO, is a multistep
process. The first step involves the binding of origin recognition complexes (Orc) to
replication origins. Orc1, Orc5, and Orc6 had decreased expression levels in both cell
lines, indicating decreased DNA synthesis. Next in this process is the recruitment of
Cdc6 and multiple Mcm proteins (minichromosome maintence proteins) to form a
complex. Cdc6, along with a majority of Mcm genes like Mcm3, Mcm4, and Mcm6 had
lower expression in both cell lines. Since this complex needs to become activated to
initiate DNA synthesis, lower expression of these genes could indicate a hindering of
DNA synthesis at lower culture temperatures and result in a slower cell growth rate (Tye
1999). Other GO terms included Carbohydrate Metabolic Process and Regulation of
Glycoprotein Metabolic Process (Figure 3.18). For the Carbohydrate Metabolic Process
GO category, Man2a1, Man2b1, Man2b2 and Man2c1 were observed to have higher
expression levels, which are mannosidases involved in N-glycan chain extension.
Specifically, Man2a1 is an a-Mannosidase that cleaves mannoses, which is a required
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trimming reaction before the formation of N-glycan residue during the glycosylation
process (Ha et al. 2015). The Response to Cold GO category had genes with mostly
higher expression for both cell lines, where the well characterized cold-shock genes
Rbm3 and Cirbp are shown (Figure 3.19). Unlike cell cycle-related genes, genes involved
in central metabolic pathways did not have any type of coordinated response to reduce
culture temperatures for CHO K1-PF or rCHO DP-12. GO categories for metabolic
pathways, Glycolytic Process and the Tricarboxylic Acid Cycle, were assessed (Figure
3.20). While the Tricarboxylic acid (TCA) cycle had 14 enriched GO terms, only Pdha1
had a higher than 1.3-fold difference for both cell lines. For the Glycolytic Process Go
category, 6 of the 7 genes had lower expression in at least one cell line. However, Pkm
was the only gene to have a greater than 1.5-fold difference which was only observed in
CHO K1-PF.
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CHAPTER 4
SUMMARY AND CONCLUSIONS

CHO cells are the most widely used mammalian cell line for producing complex
biologics due to their history of safety, high specific productivity, and ability to be
adapted to serum-free suspension systems, especially at an industrial scale. While more
than 100-fold yield improvement for biologics produced in CHO cells has resulted in the
last few decades, increasing demands for biotherapeutics persists. Process parameters,
such as temperature and pH, have a significant effect on CHO cell performance.
Lowering the culture temperature, for example, has been shown to improve recombinant
protein production depending on the cell line used. Lowering the culture pH has also
been implemented to increase product titers. In this study, two CHO cell lines, a nonrecombinant CHO K1-PF and recombinant rCHO DP-12, were used to assess the impact
of reduced culture temperature and reduced pH. Due to the minimal influence of pH in
the range investigated, only temperature effects were analyzed for differential expression
analysis. A total of 4184 temperature-sensitive genes were identified and used to assess
the impact temperature had on cold and heat shock, cell cycle, glycosylation and
apoptosis gene expression levels. Glycosylation-related genes impacted by temperature
included solute carrier family members Slc35a1 and Slc35d1 and the sialidases Neu1 and
Neu2. While improved enzymatic control for glycosylation of biologic drugs has been
noted in past studies at reduced culture temperatures, investigating gene expression
changes can give insight into why these changes occur. Cell cycle related genes, like
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cyclins and cell division-related genes, were also found to be temperature sensitive with
mostly lower expression levels observed. Slow growth rates at lower temperatures is
most likely the result of these genes having lower expression. Apoptosis did not have any
type of coordinated response, which differs from reports of decreased apoptotic
expression levels of CHO cells at reduced culture temperature. In the future, using
apoptotic assays at the time of mRNA extraction, like immunofluorescence or flow
cytometry, could provide a link between gene expression and overall apoptosis levels for
each cell line grown in different conditions. Additionally, if apoptotic related genes have
a more coordinated response later in the cell culture, linking a change in gene expression
to improve anti-apoptosis, like silencing Bid or Bax genes, could be investigated via RNA
interference in future cell line engineering studies. A GO analysis was used to identify
other major gene expression patterns, where genes in subcategories like Cell Cycle DNA
Replication (GO:0044786) had lower expression for both cell lines, while genes in GO
categories like Tricarboxylic Acid Cycle (GO:0006099) and Glycolytic Process
(0006096) did not show any trends. GO analysis could be used further to assess other
pathways and investigate specific gene expression trends within different GO categories.
Additionally, future work could involve investigating other types of ‘omics studies, such
as proteomics and metabolomics, to attain a better understanding of how reduced culture
temperatures and pH impacts the cellular and biological processes of CHO cells.
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APPENDIX A
Sample Descriptions

Table A-1: NCBI-BioProject Sequence Read Archive (SRA) accession numbers. The
RNA-Seq data was submitted to the public database of the National Institutes of Health
(NIH). Listed below are the cell lines, culture temperature, pH, and principle component
coordinate values corresponding to Figure 3.3. The data can be accessed in the NCBI
BioProject database (https://www.ncbi.nlm.nih.gov/bioproject).
BioProject # PRJNA378769
Sequence Read
Cell Line
Archive Accession #

Culture Conditions
Temperature (°C)

Coordinate Values

pH

PC1

PC2

SAMN06560482

rCHO DP-12 clone 1934

37

6.95

-13.17

-3.98

SAMN06560483

rCHO DP-12 clone 1934

37

6.95

-13.32

-3.99

SAMN06560484

rCHO DP-12 clone 1934

33

6.95

-11.77

5.01

SAMN06560485

rCHO DP-12 clone 1934

33

6.95

-11.89

4.48

SAMN06560486

rCHO DP-12 clone 1934

37

6.7

-13.12

-4.08

SAMN06560487

rCHO DP-12 clone 1934

37

6.7

-13.22

-4.07

SAMN06560488

rCHO DP-12 clone 1934

33

6.7

-11.45

4.94

SAMN06560489

rCHO DP-12 clone 1934

33

6.7

-11.44

5.01

SAMN06560490

CHO K1-PF

37

6.95

14.12

-9.11

SAMN06560491

CHO K1-PF

37

6.95

13.81

-9.46

SAMN06560492

CHO K1-PF

33

6.95

17.58

3.43

SAMN06560493

CHO K1-PF

33

6.95

18.11

3.37

SAMN06560494

CHO K1-PF

33

6.7

17.8

4.24

SAMN06560495

CHO K1-PF

33

6.7

17.96

4.21
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APPENDIX B
MDS PLOT

Figure B-1: Multi-dimension scaling (MDS) plots representing gene expression
profiles for all samples.

76

APPENDIX C: Differentially Expressed Genes List

Table C-1: Genes that were identified as temperature sensitive in at least one of the cell
lines (FDR ≤ 0.05 and FD ≥ 1.5). The gene expression fold-differences are shown for the
33°C cultures relative to the 37°C cultures. Blanks indicate genes that did not meet these
criteria.

Fold Difference
Gene Symbol
Abcb1
Adamts14
Adgrv1
Adm
Agt
Ahnak2
Angptl4
Aprt
Areg
Arhgap31
Asap3
Asb13
Aspm
Aurka
Azin1
Bard1
Bax
Baz1b
Bckdha
Bet1l
Bora
Btg2
C1r
C1rl
Cacna1i
Calhm2
Calhm5
Capn12
Casp3

Gene Description
ATP binding cassette subfamily B member 1
ADAM metallopeptidase with thrombospondin
type 1 motif 14
adhesion G protein-coupled receptor V1
adrenomedullin
angiotensinogen
AHNAK nucleoprotein 2
angiopoietin like 4
adenine phosphoribosyltransferase
amphiregulin
Rho GTPase activating protein 31
ArfGAP with SH3 domain, ankyrin repeat and PH
domain 3
ankyrin repeat and SOCS box containing 13
abnormal spindle microtubule assembly
aurora kinase A
antizyme inhibitor 1
BRCA1 associated RING domain 1
BCL2 associated X, apoptosis regulator
bromodomain adjacent to zinc finger domain 1B
branched chain keto acid dehydrogenase E1, alpha
polypeptide
Bet1 golgi vesicular membrane trafficking protein
like
bora, aurora kinase A activator
BTG anti-proliferation factor 2
complement C1r
complement C1r subcomponent like
calcium voltage-gated channel subunit alpha1 I
calcium homeostasis modulator family member 2
calcium homeostasis modulator family member 5
calpain 12
caspase 3, apoptosis-related cysteine peptidase
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CHO
K1-PF

rCHO
DP-12

-2.0
4.8
9.9
2.2
-15.9
2.0
3.3
1.9
-2.2
-2.0
3.1
2.1
-2.2
-2.3
-1.8
-3.0
2.2
-1.8
2.1

4.6

-1.7
2.1

2.0
-1.9
20.6
1.7
4.9
3.3
2.9
24.5

12.5
3.5
2.0
2.1
2.1

Fold Difference
Gene Symbol
Casp6
Casq1
Ccdc122
Ccdc24
Ccn2
Ccna2
Ccnb1
Ccnb2
Ccnf
Ccng1
Cd28
Cd59
Cd81
Cdc25b
Cdc42ep2
Cdc6
Cdca8
Cdr2
Cdsn
Cdt1
Cenpa
Cir1
Cirbp
Ckap2l
Cks2
Col3a1
Cpn1
Crybg1
Cspg4
Ctnnal1
Ctsd
CUNH3orf70
Cxcl12
Cxcl3
Dapk1
Dbf4
Dchs1
Dclk1
Dcps
Ddit4

Gene Description
caspase 6
calsequestrin 1
coiled-coil domain containing 122
coiled-coil domain containing 24
cellular communication network factor 2
cyclin A2
cyclin B1
cyclin B2
cyclin F
cyclin G1
CD28 molecule
CD59 molecule (CD59 blood group)
CD81 molecule
cell division cycle 25B
CDC42 effector protein 2
cell division cycle 6
cell division cycle associated 8
cerebellar degeneration related protein 2
corneodesmosin
chromatin licensing and DNA replication factor 1
centromere protein A
corepressor interacting with RBPJ, 1
cold inducible RNA binding protein
cytoskeleton associated protein 2 like
CDC28 protein kinase regulatory subunit 2
collagen type III alpha 1 chain
carboxypeptidase N subunit 1
crystallin beta-gamma domain containing 1
chondroitin sulfate proteoglycan 4
catenin alpha like 1
cathepsin D
chromosome unknown C3orf70 homolog
C-X-C motif chemokine ligand 12
chemokine (C-X-C motif) ligand 3
death associated protein kinase 1
DBF4 zinc finger
dachsous cadherin-related 1
doublecortin like kinase 1
decapping enzyme, scavenger
DNA damage inducible transcript 4
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CHO
K1-PF

2.4
4.9
7.8
-4.7

rCHO
DP-12

5.1
-5.3

-2.6
-2.6
-2.1
-2.5
2.7
2.8
2.3
-2.6

-1.8
3.0
-4.0
1.8
2.9

-2.3
-2.2
-2.8
3.3
-2.3
-2.4
2.7
2.2
-1.9
-2.3

2.1
-1.7
2.1
2.3

3.0
-2.8
-2.5
-2.0
1.8
2.4
2.6
5.2
2.8
-2.2
12.7
2.4
-1.9
8.4

2.1

Fold Difference
Gene Symbol
Ddx20
Des
Dhcr24
Dhfr
Dipk1c
Dkc1
Dlgap5
Dnase1l1
Dock6
Donson
Dpyd
Drc7
Duoxa1
Dusp1
Dusp4
Dzip1
Ebp
Edn1
Efcab8
Egr1
Enc1
Epas1
Ercc6l
Ereg
Esco2
Etnk1
Exd1
Exoc4
Ezr
F2r
Fabp4
Fads6
Fam163a
Fam189a2
Fam43a
Fam83d
Fbxo32
Fbxo5

Gene Description
DEAD-box helicase 20
desmin
24-dehydrocholesterol reductase
dihydrofolate reductase
divergent protein kinase domain 1C
dyskerin pseudouridine synthase 1
DLG associated protein 5
deoxyribonuclease 1 like 1
dedicator of cytokinesis 6
downstream neighbor of SON
dihydropyrimidine dehydrogenase
dynein regulatory complex subunit 7
dual oxidase maturation factor 1
dual specificity phosphatase 1
dual specificity phosphatase 4
DAZ interacting zinc finger protein 1
EBP, cholestenol delta-isomerase
endothelin 1
EF-hand calcium binding domain 8
early growth response 1
ectodermal-neural cortex 1
endothelial PAS domain protein 1
ERCC excision repair 6 like, spindle assembly
checkpoint helicase
epiregulin
establishment of sister chromatid cohesion Nacetyltransferase 2
ethanolamine kinase 1
exonuclease 3'-5' domain containing 1
exocyst complex component 4
ezrin
coagulation factor II thrombin receptor
fatty acid binding protein 4
fatty acid desaturase 6
family with sequence similarity 163 member A
family with sequence similarity 189 member A2
family with sequence similarity 43 member A
family with sequence similarity 83 member D
F-box protein 32
F-box protein 5
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CHO
K1-PF

rCHO
DP-12

-2.2
8.1
-1.8
-2.0
3.0
-2.0
-2.3
2.4
4.0
-1.9
3.2
14.9
3.2

26.0
2.7
-2.2

7.4
-1.8
5.6
3.7
-2.0
2.5
2.6
-2.5
-2.7
-2.2
1.9
2.9
3.0
1.9
2.7
211.3
16.3
3.0
4.7
-2.1
2.1
-2.4

2.5
1.8

3.1

Fold Difference
Gene Symbol
Fbxw7
Fech
Fmnl1
Fndc10
Fstl1
Fzd5
Gabarapl1
Gabrr3
Gask1b
Gba
Gfer
Gins1
Glud1
Gmnn
Gng11
Got1
Gpr152
Gpr153
Gpr158
Gprasp2
Gpsm3
Grina
Grn
Gsdme
Hap1
Hapln4
Hdgf
Hfe
Higd2a
Hmgb1
Hmmr
Hnrnpd
Hs6st3
Hsbp1
Hsd11b1
Hsd3b7

Gene Description
F-box and WD repeat domain containing 7
ferrochelatase
formin like 1
fibronectin type III domain containing 10
follistatin like 1
frizzled class receptor 5
GABA type A receptor associated protein like 1
gamma-aminobutyric acid type A receptor rho3
subunit
golgi associated kinase 1B
glucosylceramidase beta
growth factor, augmenter of liver regeneration
GINS complex subunit 1
glutamate dehydrogenase 1
geminin, DNA replication inhibitor
G protein subunit gamma 11
glutamic-oxaloacetic transaminase 1
G protein-coupled receptor 152
G protein-coupled receptor 153
G protein-coupled receptor 158
G protein-coupled receptor associated sorting
protein 2
G protein signaling modulator 3
glutamate ionotropic receptor NMDA type subunit
associated protein 1
granulin precursor
gasdermin E
huntingtin associated protein 1
hyaluronan and proteoglycan link protein 4
heparin binding growth factor
homeostatic iron regulator
HIG1 hypoxia inducible domain family member
2A
high mobility group box 1
hyaluronan mediated motility receptor
heterogeneous nuclear ribonucleoprotein D
heparan sulfate 6-O-sulfotransferase 3
heat shock factor binding protein 1
hydroxysteroid 11-beta dehydrogenase 1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and
steroid delta-isomerase 7
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CHO
K1-PF

rCHO
DP-12

43.8
2.1
6.1
4.2
1.7

2.7
-2.3

2.0
6.4
3.8
2.1
2.0
-2.0
1.8
-1.9
2.2

1.7
-1.7
3.6

9.8
10.1
3.8
2.2
2.4
2.5
3.4
81.6
2.2
-2.9
2.2
2.0

77.3

-2.0
-2.0
-1.8
4.2
2.9
6.4
2.7

Fold Difference
Gene Symbol
Hspb1
Hspd1
Htr1b
Icam1
Ifi35
Ifitm3
Ifrd2
Il33
Inka2
Insig1
Ints4
Isg15
Itga9
Itih5
Itm2b
Itm2c
Kcp
Kctd11
Kctd17
Kctd17
Kif20a
Kif23
Kif2c
Kif4a
Kifc1
Klf4
Knstrn
Kpna2
Kpnb1
Lama3
Ldb3
Lgals3bp
Lgi4
Lif
Lmnb1
Lpl

Gene Description
heat shock protein family B (small) member 1
heat shock protein family D (Hsp60) member 1
5-hydroxytryptamine receptor 1B
intercellular adhesion molecule 1
interferon induced protein 35
interferon induced transmembrane protein 3
interferon related developmental regulator 2
interleukin 33
inka box actin regulator 2
insulin induced gene 1
integrator complex subunit 4
ISG15 ubiquitin-like modifier
integrin subunit alpha 9
inter-alpha-trypsin inhibitor heavy chain family
member 5
integral membrane protein 2B
integral membrane protein 2C
kielin cysteine rich BMP regulator
potassium channel tetramerization domain
containing 11
potassium channel tetramerization domain
containing 17
potassium channel tetramerization domain
containing 17
kinesin family member 20A
kinesin family member 23
kinesin family member 2C
kinesin family member 4A
kinesin family member C1
Kruppel like factor 4
kinetochore localized astrin (SPAG5) binding
protein
karyopherin subunit alpha 2
karyopherin subunit beta 1
laminin subunit alpha 3
LIM domain binding 3
galectin 3 binding protein
leucine rich repeat LGI family member 4
LIF, interleukin 6 family cytokine
lamin B1
lipoprotein lipase
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CHO
K1-PF

2.2
-1.8

rCHO
DP-12

-1.7
-2.6

1.9
2.9
2.0
-2.3
6.3
-2.1
2.0

-5.6
8.7
2.1

115.2
1.9
1.9
2.2
8.8
3.4

1.8

2.3
2.1
-2.1
-2.1
-2.1
-2.2
-4.0
2.0
-2.1
-2.1
-1.8
3.9
23.1
4.5
4.2
5.0
-2.4

2.4

3.6
3.9
1.8

Fold Difference
Gene Symbol
Lrrc59
Lss
Lxn
Mad2l1
Malrd1
Man2b2
Maoa
Map1lc3b
Mcm3
Mcm7
Med4
Mei4
Mettl16
Mettl7a
Mis18a
Mmd
Mmp12
Mmp24
Mms22l
Moxd1
Mthfd2
Naglu
Nampt
Nasp
Ncl
Ndufc2
Neil3
Nek11
Nek2
Neu1
Neu2
Neurl1b
Neurl3
Nnmt
Notch3
Nppb

Gene Description
leucine rich repeat containing 59
lanosterol synthase
latexin
mitotic arrest deficient 2 like 1
MAM and LDL receptor class A domain
containing 1
mannosidase alpha class 2B member 2
monoamine oxidase A
microtubule associated protein 1 light chain 3 beta
minichromosome maintenance complex component
3
minichromosome maintenance complex component
7
mediator complex subunit 4
meiotic double-stranded break formation protein 4
methyltransferase like 16
methyltransferase like 7A
MIS18 kinetochore protein A
monocyte to macrophage differentiation associated
matrix metallopeptidase 12
matrix metallopeptidase 24
MMS22 like, DNA repair protein
monooxygenase DBH like 1
methylenetetrahydrofolate dehydrogenase (NADP+
dependent) 2, methenyltetrahydrofolate
cyclohydrolase
N-acetyl-alpha-glucosaminidase
nicotinamide phosphoribosyltransferase
nuclear autoantigenic sperm protein
nucleolin
NADH:ubiquinone oxidoreductase subunit C2
nei like DNA glycosylase 3
NIMA related kinase 11
NIMA related kinase 2
neuraminidase 1
neuraminidase 2
neuralized E3 ubiquitin protein ligase 1B
neuralized E3 ubiquitin protein ligase 3
nicotinamide N-methyltransferase
notch 3
natriuretic peptide B
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CHO
K1-PF

rCHO
DP-12

-1.8
-2.1
2.1
-2.0
5.9

2.6

2.0
2.4
2.3
-1.9

2.2

-1.8
2.3
26.2
-1.9
3.3
-2.6

2.2
2.2
-2.2

-3.7
-2.0
17.3

2.3
-1.9
-2.5
-1.9
2.2
2.5
7.7
-2.1
2.4
-3.2
-2.6

6.9
-1.8

-2.2

-3.7
-2.1
2.7

2.8
2.8

Fold Difference
Gene Symbol
Npr2
Nr1d1
Nrg2
Nsdhl
Nup37
Nup85
Nupr1
Oip5
Opn4
Orc1
Orc6
Osr1
Ostf1
P2rx4
P2ry1
Pabpc1
Pak1
Parp14
Parpbp
Paxip1
Paxx
Pcif1
Pclaf
Pcolce
Pdgfc
Pdia5
Peg10
Pgap2
Phf19
Phlda3
Pink1
Pkp1
Pla2g7
Plat
Plin3
Plk1
Plk2
Plpp3
Plpp6

Gene Description
natriuretic peptide receptor 2
nuclear receptor subfamily 1 group D member 1
neuregulin 2
NAD(P) dependent steroid dehydrogenase-like
nucleoporin 37
nucleoporin 85
nuclear protein 1, transcriptional regulator
Opa interacting protein 5
opsin 4
origin recognition complex subunit 1
origin recognition complex subunit 6
odd-skipped related transciption factor 1
osteoclast stimulating factor 1
purinergic receptor P2X 4
purinergic receptor P2Y1
poly(A) binding protein cytoplasmic 1
p21 (RAC1) activated kinase 1
poly(ADP-ribose) polymerase family member 14
PARP1 binding protein
PAX interacting protein 1
PAXX, non-homologous end joining factor
PDX1 C-terminal inhibiting factor 1
PCNA clamp associated factor
procollagen C-endopeptidase enhancer
platelet derived growth factor C
protein disulfide isomerase family A member 5
paternally expressed 10
post-GPI attachment to proteins 2
PHD finger protein 19
pleckstrin homology like domain family A member
3
PTEN induced kinase 1
plakophilin 1
phospholipase A2 group VII
plasminogen activator, tissue type
perilipin 3
polo like kinase 1
polo like kinase 2
phospholipid phosphatase 3
phospholipid phosphatase 6
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CHO
K1-PF

rCHO
DP-12

2.5
2.0
-4.0
-2.0
-1.9
-1.9
2.4
-2.2
8.5
-2.1
-1.9
3.1
1.7
2.3
2.3
-1.7
3.0
2.5
-2.6
-1.9
3.1
-2.3
2.7
1.9
2.2
2.4
-2.2
2.4
4.0
4.7
2.2
2.3
2.2
-2.5
4.8
1.9
2.0

2.1
4.4

1.8
-2.8
2.3
2.0
2.7

1.9

Fold Difference
Gene Symbol
Pm20d2
Pole
Ppid
Pqlc3
Prom2
Psat1
Ptger4
Ptgr1
Ptma
Qsox1
Rab27b
Rabgap1
Rad54l
Ranbp1
Rarres2
Rasl11a
Rbm3
Rdh14
Retsat
Rgs16
Rnf145
Rnf169
Rnf20
Rprm
Rpusd3
Rsf1
Rtl9
Rtn4rl1
Rxfp4
S100a11
Sarm1
Scly
Sel1l3
Selenom
Selenop
Sema3c
Sept11
Serinc4
Serpine1

Gene Description
peptidase M20 domain containing 2
DNA polymerase epsilon, catalytic subunit
peptidylprolyl isomerase D
PQ loop repeat containing 3
prominin 2
phosphoserine aminotransferase 1
prostaglandin E receptor 4
prostaglandin reductase 1
prothymosin alpha
quiescin sulfhydryl oxidase 1
RAB27B, member RAS oncogene family
RAB GTPase activating protein 1
RAD54 like
RAN binding protein 1
retinoic acid receptor responder 2
RAS like family 11 member A
RNA binding motif protein 3
retinol dehydrogenase 14
retinol saturase
regulator of G protein signaling 16
ring finger protein 145
ring finger protein 169
ring finger protein 20
reprimo, TP53 dependent G2 arrest mediator
homolog
RNA pseudouridine synthase D3
remodeling and spacing factor 1
retrotransposon Gag like 9
reticulon 4 receptor like 1
relaxin family peptide/INSL5 receptor 4
S100 calcium binding protein A11
sterile alpha and TIR motif containing 1
selenocysteine lyase
SEL1L family member 3
selenoprotein M
selenoprotein P
semaphorin 3C
septin 11
serine incorporator 4
serpin family E member 1
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CHO
K1-PF

rCHO
DP-12

2.5
-1.8
-5.5

-3.6
1.9
16.6

-2.0
2.0
-1.8
-1.9
2.1
8.4
3.9
-2.0
-1.8
2.5
6.2
2.5
3.9
-2.4
2.1
2.8
5.6
1.9

5.2
2.5

2.1
2.9
1.8
2.9
1.9
3.0

2.1
2.1
4.0
2.1
3.4
1.9
7.1
-2.7
2.1
2.4

5.2

1.8
2.3
-1.8
2.3
1.8

2.4

Fold Difference
Gene Symbol
Sgca
Sh3rf3
Shmt1
Ska3
Slc16a1
Slc25a23
Slc35d1
Slc44a1
Slc46a1
Slc48a1
Slc9a9
Slpi
Smc4
Smg5
Smim4
Sorl1
Spag5
Spdef
Spn
Sqstm1
Sspn
Ssu72
Stap2
Stk24
Sulf2
Sumf1
Susd6
Syngap1
Synpo2
Taf15
Tap2
Tax1bp3
Tbc1d8
Tdgf1
Tenm3
Tes
Tgfbr3

Gene Description
sarcoglycan alpha
SH3 domain containing ring finger 3
serine hydroxymethyltransferase 1
spindle and kinetochore associated complex
subunit 3
solute carrier family 16 member 1
solute carrier family 25 member 23
solute carrier family 35 member D1
solute carrier family 44 member 1
solute carrier family 46 member 1
solute carrier family 48 member 1
solute carrier family 9 member A9
secretory leukocyte peptidase inhibitor
structural maintenance of chromosomes 4
SMG5, nonsense mediated mRNA decay factor
small integral membrane protein 4
sortilin related receptor 1
sperm associated antigen 5
SAM pointed domain containing ETS transcription
factor
sialophorin
sequestosome 1
sarcospan
SSU72 homolog, RNA polymerase II CTD
phosphatase
signal transducing adaptor family member 2
serine/threonine kinase 24
sulfatase 2
sulfatase modifying factor 1
sushi domain containing 6
synaptic Ras GTPase activating protein 1
synaptopodin 2
TATA-box binding protein associated factor 15
transporter 2, ATP binding cassette subfamily B
member
Tax1 binding protein 3
TBC1 domain family member 8
teratocarcinoma-derived growth factor 1
teneurin transmembrane protein 3
testin LIM domain protein
transforming growth factor beta receptor 3
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CHO
K1-PF

rCHO
DP-12

7.3
3.2
-2.0
-2.6
-2.0
2.7
1.9
3.2
3.1
2.1
1.9
4.6
-2.8
-1.8
3.9
-2.8
-2.1
5.0
4.0
1.8
2.4
2.2
3.3
-7.1
70.9
1.9
2.6
2.1
3.4

2.0
3.0
2.5
2.0
2.6

-1.7

2.8

2.1
-1.9

2.5
3.0
5.6
2.3
8.0
1.9
1.9

2.6
2.9
18.3

Fold Difference
Gene Symbol
Thbd
Thra
Ticrr
Timeless
Timp2
Tlr2
Tmbim1
Tmc4
Tmed4
Tmeff2
Tmem123
Tmem150a
Tmem151b
Tmem203
Tmem38a
Tmem43
Tmem50b
Tmem63b
Tmem86a
Tmem8a
Tmem97
Tmpo
Tnfsf4
Top2a
Tor4a
Tp53inp1
Tpp1
Tprg1
Trabd2b
Traip
Trappc1
Trim54
Trip13
Trpm6
Tsta3
Tulp3
Txnip
Ube2c

Gene Description
thrombomodulin
thyroid hormone receptor alpha
TOPBP1 interacting checkpoint and replication
regulator
timeless circadian regulator
TIMP metallopeptidase inhibitor 2
toll like receptor 2
transmembrane BAX inhibitor motif containing 1
transmembrane channel like 4
transmembrane p24 trafficking protein 4
transmembrane protein with EGF like and two
follistatin like domains 2
transmembrane protein 123
transmembrane protein 150A
transmembrane protein 151B
transmembrane protein 203
transmembrane protein 38A
transmembrane protein 43
transmembrane protein 50B
transmembrane protein 63B
transmembrane protein 86A
transmembrane protein 8A
transmembrane protein 97
thymopoietin
TNF superfamily member 4
DNA topoisomerase II alpha
torsin family 4 member A
tumor protein p53 inducible nuclear protein 1
tripeptidyl peptidase 1
tumor protein p63 regulated 1
TraB domain containing 2B
TRAF interacting protein
trafficking protein particle complex 1
tripartite motif containing 54
thyroid hormone receptor interactor 13
transient receptor potential cation channel
subfamily M member 6
tissue specific transplantation antigen P35B
tubby like protein 3
thioredoxin interacting protein
ubiquitin conjugating enzyme E2 C
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CHO
K1-PF

rCHO
DP-12

2.4
2.4
-2.3
-1.8
1.9
2.4
2.8
2.0
1.8
2.9
3.4
3.3
2.3
2.4
3.0
2.0
2.6
4.5
4.2
2.1
-2.1
-2.6
4.8
-2.2
2.9
8.1
2.2
5.6

1.8
1.9
6.2
1.9
2.1

2.0
3.7

2.3
9.8
2.3

-2.2
2.1
6.3
-1.8
4.2
2.0
2.1
2.0
-3.0

2.4

2.2
-1.8

Fold Difference
Gene Symbol
Ube2s
Ugcg
Uggt2
Usp1
Usp35
Vangl2
Vnn1
Vwa2
Wfikkn1
Wfs1
Wipi1
Wnk4
Wwox
Xpnpep2
Xrcc2
Ypel1
Ypel2
Zadh2
Zc3h6
Zmat3
Znf365
Zwint
LOC103160274
LOC103159983
LOC100771285
LOC100760000
LOC100753241
LOC100769250
LOC100763954
LOC113830710
LOC100767344
LOC100773073
LOC100770874
LOC103158905
LOC113834873
LOC100763833
LOC100763261

Gene Description
ubiquitin conjugating enzyme E2 S
UDP-glucose ceramide glucosyltransferase
UDP-glucose glycoprotein glucosyltransferase 2
ubiquitin specific peptidase 1
ubiquitin specific peptidase 35
VANGL planar cell polarity protein 2
vanin 1
von Willebrand factor A domain containing 2
WAP, follistatin/kazal, immunoglobulin, kunitz
and netrin domain containing 1
wolframin ER transmembrane glycoprotein
WD repeat domain, phosphoinositide interacting 1
WNK lysine deficient protein kinase 4
WW domain containing oxidoreductase
X-prolyl aminopeptidase 2
X-ray repair cross complementing 2
yippee like 1
yippee like 2
zinc binding alcohol dehydrogenase domain
containing 2
zinc finger CCCH-type containing 6
zinc finger matrin-type 3
zinc finger protein 365
ZW10 interacting kinetochore protein
3-beta-hydroxysteroid sulfotransferase-like
60S ribosomal protein L17
60S ribosomal protein L36 pseudogene
acetyl-CoA acetyltransferase, cytosolic
acyl-CoA desaturase 4
acylcarnitine hydrolase
amiloride-sensitive amine oxidase [coppercontaining]
angiotensin II receptor type 2
annexin A7 pseudogene
annexin A8
ATP-binding cassette sub-family A member 3-like
ATP-dependent RNA helicase DHX8
BTB/POZ domain-containing protein KCTD14like
C-C motif chemokine 2
C-C motif chemokine 7

87

CHO
K1-PF

-1.9
2.1
2.1
-2.2
3.4
2.3
3.5
14.2
3.5
2.2
1.9
2.2
2.0
4.1
-2.0
4.4
2.7
1.9
5.5

rCHO
DP-12

2.0

2.1
2.0

2.0
2.3
3.3
2.7

-2.0
-18.8
3.0
-6.7
-2.2
4.7
62.7

27.9
-3.4

8.3
6.9
17.9
44.2
1.7
3.1

65.2
31.4

2.8
5.7

1.7
2.4

Fold Difference
CHO
K1-PF

rCHO
DP-12

LOC103160461 C-type lectin domain family 2 member A
LOC100761692 C-type lectin domain family 2 member D11
LOC113833874 calcium/calmodulin-dependent protein kinase II

3.0
2.9
2.6

4.0

LOC113833727 centrosomal protein of 55 kDa
LOC100755608 chromosome unknown open reading frame, human

-2.1
1.9

Gene Symbol

Gene Description

inhibitor 1

LOC100772424
LOC100760794
LOC100761082
LOC107979148
LOC100756343
LOC100751341
LOC100760951
LOC100772471
LOC100768211
LOC113838100
LOC113833115
LOC103164600
LOC100757489
LOC100753467
LOC100767530
LOC100753288
LOC113833391
LOC113832455
LOC113833176
LOC100758202
LOC100763852
LOC100761268
LOC113835792
LOC107977182
LOC113833125
LOC100689011
LOC100773718
LOC113836370
LOC100773141
LOC100772072
LOC100756978

C4orf3
chromosome unknown open reading frame, human
C8orf48
class II histocompatibility antigen, M alpha chain
class II histocompatibility antigen, M beta 1 chain
clathrin light chain A pseudogene
coiled-coil domain-containing protein 171
complement factor H-related protein 2-like
cornifin alpha
cytochrome c oxidase assembly protein COX14
cytochrome P450 4A14
desmoglein-2-like
ephrin A4, transcript variant X1
gasdermin-A-like
glutamyl aminopeptidase
glutathione S-transferase alpha-3
glutathione S-transferase Mu 3
glycogen phosphorylase, liver form
growth/differentiation factor 15-like
H-2 class I histocompatibility antigen, Q10 alpha
chain-like
helix-loop-helix protein 2
heterogeneous nuclear ribonucleoprotein C-like
histone H2A.Z
histone H2B type 1
interferon alpha-inducible protein 27-like protein
2B
interferon-induced very large GTPase 1-like
late cornified envelope protein 1C-like
MHC class I antigen Hm1-C3
MLV-related proviral Env polyprotein-like
MMP24 opposite strand
MOB-like protein phocein
myomegalin
nucleophosmin pseudogene
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1.9
3.3
5.4
-3.0
-3.8
14.8
3.9
2.1
6.3
-4.9
2.5
4.1
7.3
3.9
5.0
4.0
107.3
3.7
3.2
-2.0
-2.2
11.0

2.1

3.1

-1.7
3.2
-2.7

3.8
2.3
3.4
2.0
-2.1
2.4
-1.9

2.1
-1.8

Fold Difference
Gene Symbol

Gene Description

LOC100762223 nucleosome assembly protein 1-like 1 pseudogene
LOC100755641 peptidyl-prolyl cis-trans isomerase D-like
LOC100772948 poly(A)-specific ribonuclease PARN-like domainLOC113831948
LOC113832707
LOC113834099
LOC113836540
LOC113833705
LOC100771727
LOC100772593
LOC100754141
LOC113833573
LOC113838544
LOC100754646
LOC100768367
LOC113836685
LOC100754565
LOC113837993
LOC100755423
LOC100769218
LOC100761126
LOC100761886
LOC113830743
LOC100751512
LOC100754175
LOC100754872
LOC100764856
LOC100773771
LOC103158756
LOC103159189
LOC103159228
LOC103159336
LOC103159353
LOC103159433
LOC103159534
LOC103159589
LOC103159835
LOC103160142
LOC103160523

containing protein 1 pseudogene
PRAME family member 8-like
protein phosphatase 1 regulatory subunit 3E
protein SET-like
prothymosin alpha-like
protocadherin beta-14-like, transcript variant X1
protocadherin beta-3
protocadherin beta-5-like
protocadherin gamma-B1
putative fidgetin-like protein 2
putative protein ZNF720, transcript variant X1
putative small proline-rich protein 2J
retinal dehydrogenase 1
serine/arginine-rich splicing factor 2-like
stromelysin-1-like
translation initiation factor IF-2-like
UDP-glucuronosyltransferase 1-6
zinc finger protein 420
zinc finger protein 431-like
zinc finger protein 883
uncharacterized LOC113830743
uncharacterized LOC100751512
uncharacterized LOC100754175
uncharacterized LOC100754872
uncharacterized LOC100764856
uncharacterized LOC100773771
uncharacterized LOC103158756
uncharacterized LOC103159189
uncharacterized LOC103159228
uncharacterized LOC103159336
uncharacterized LOC103159353
uncharacterized LOC103159433
uncharacterized LOC103159534
uncharacterized LOC103159589
uncharacterized LOC103159835
uncharacterized LOC103160142
uncharacterized LOC103160523
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CHO
K1-PF

rCHO
DP-12

-1.8
-5.6
5.9

-3.6
-2.9

2.2
-3.4
-2.0
6.1
2.5
3.6
2.6
2.7
10.2
2.0
3.1
-1.8

3.8
-2.9

-8.7
2.1
2.6
-2.0
-2.1
2.0
4.3
12.1
15.7
3.8
19.2
30.8
3.3
5.9
7.6

2.2
2.2
-2.4

4.5

-15.8
2.4
5.4
2.7
3.1

Fold Difference
Gene Symbol
LOC103160860
LOC103161056
LOC103161127
LOC103161423
LOC103161512
LOC103161665
LOC103162230
LOC103162302
LOC103162356
LOC103162751
LOC103163253
LOC103163716
LOC103163843
LOC103163910
LOC107978267
LOC107978279
LOC107978535
LOC107978541
LOC107978675
LOC107978970
LOC107979404
LOC107979406
LOC107979474
LOC107979531
LOC107979615
LOC107979868
LOC107979955
LOC107980313
LOC107980379
LOC113830912
LOC113830989
LOC113831598
LOC113832576
LOC113832687
LOC113832972
LOC113833126
LOC113833189
LOC113833204
LOC113833272
LOC113833275

Gene Description
uncharacterized LOC103160860
uncharacterized LOC103161056
uncharacterized LOC103161127
uncharacterized LOC103161423
uncharacterized LOC103161512
uncharacterized LOC103161665
uncharacterized LOC103162230
uncharacterized LOC103162302
uncharacterized LOC103162356
uncharacterized LOC103162751
uncharacterized LOC103163253
uncharacterized LOC103163716
uncharacterized LOC103163843
uncharacterized LOC103163910
uncharacterized LOC107978267
uncharacterized LOC107978279
uncharacterized LOC107978535
uncharacterized LOC107978541
uncharacterized LOC107978675
uncharacterized LOC107978970
uncharacterized LOC107979404
uncharacterized LOC107979406
uncharacterized LOC107979474
uncharacterized LOC107979531
uncharacterized LOC107979615
uncharacterized LOC107979868
uncharacterized LOC107979955
uncharacterized LOC107980313
uncharacterized LOC107980379
uncharacterized LOC113830912
uncharacterized LOC113830989
uncharacterized LOC113831598
uncharacterized LOC113832576
uncharacterized LOC113832687
uncharacterized LOC113832972
uncharacterized LOC113833126
uncharacterized LOC113833189
uncharacterized LOC113833204
uncharacterized LOC113833272
uncharacterized LOC113833275
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CHO
K1-PF

rCHO
DP-12

5.1
9.3
3.1
4.0
6.0
16.9

2.6
24.6
-4.1
-2.6

8.1
2.7
2.0
5.8
2.8
3.6
3.6
2.4
5.4
2.3
2.4

6.9
2.7
2.4
6.5
-5.9

4.3
5.5
3.8

7.7
-6.7
4.3
-4.0

6.5
2.6
3.1
12.8
2.3
-3.3
3.6
4.4
2.9
8.2
2.7
41.0

5.6
2.7

Fold Difference
Gene Symbol
LOC113833460
LOC113833557
LOC113833858
LOC113833948
LOC113834127
LOC113834172
LOC113834875
LOC113834877
LOC113834998
LOC113835046
LOC113835047
LOC113835137
LOC113835176
LOC113835325
LOC113835610
LOC113835612
LOC113835715
LOC113835897
LOC113835917
LOC113835922
LOC113836233
LOC113836268
LOC113836333
LOC113836714
LOC113837117
LOC113837467
LOC113837481
LOC113837489
LOC113837508
LOC113837582
LOC113837758

Gene Description
uncharacterized LOC113833460
uncharacterized LOC113833557
uncharacterized LOC113833858
uncharacterized LOC113833948
uncharacterized LOC113834127
uncharacterized LOC113834172
uncharacterized LOC113834875
uncharacterized LOC113834877
uncharacterized LOC113834998
uncharacterized LOC113835046
uncharacterized LOC113835047
uncharacterized LOC113835137
uncharacterized LOC113835176
uncharacterized LOC113835325
uncharacterized LOC113835610
uncharacterized LOC113835612
uncharacterized LOC113835715
uncharacterized LOC113835897
uncharacterized LOC113835917
uncharacterized LOC113835922
uncharacterized LOC113836233
uncharacterized LOC113836268
uncharacterized LOC113836333
uncharacterized LOC113836714
uncharacterized LOC113837117
uncharacterized LOC113837467
uncharacterized LOC113837481
uncharacterized LOC113837489
uncharacterized LOC113837508
uncharacterized LOC113837582
uncharacterized LOC113837758
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CHO
K1-PF

rCHO
DP-12

2.2
6.2
2.2
2.3
-7.3
4.9
4.0
6.7
3.1
3.5
5.5
3.3
8.6
13.3
4.0
5.4
3.9
-2.0
4.0
-3.5

2.7

-7.8
2.3
3.5
2.1

-2.1
3.2
19.1
3.9
2.8
4.8
117.0
6.9

2.2

2.8
-3.5
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